<SEC-DOCUMENT>0001140361-21-038347.txt : 20211117
<SEC-HEADER>0001140361-21-038347.hdr.sgml : 20211117
<ACCEPTANCE-DATETIME>20211117172119
ACCESSION NUMBER:		0001140361-21-038347
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20211117
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211117
DATE AS OF CHANGE:		20211117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Great Elm Group, Inc.
		CENTRAL INDEX KEY:			0001831096
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				853622015
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39832
		FILM NUMBER:		211421563

	BUSINESS ADDRESS:	
		STREET 1:		800 SOUTH STREET, SUITE 230
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		(617) 375-3006

	MAIL ADDRESS:	
		STREET 1:		800 SOUTH STREET, SUITE 230
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10030953_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:geg="http://greatelmcap.com/20211117" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_99d4f61e8e4f40849a17b64ce6dfb396" contextRef="c20211117to20211117" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_2438d2ab36804d28a2ff1952957c3f94" contextRef="c20211117to20211117">MA</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_9d264ab1f4f24887aebec4fe299451ce" contextRef="c20211117to20211117">0001831096</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="geg-20211117.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20211117to20211117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831096</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-17</xbrli:startDate><xbrli:endDate>2021-11-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;"> <br />
      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

        <div style="text-align: center; margin-right: 162pt; margin-left: 162pt; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_70e56e426b8f45eeba28d1dff6b083d1" contextRef="c20211117to20211117">8-K</ix:nonNumeric></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_ad125f87080c4e55a74efeef1ebf12ef" contextRef="c20211117to20211117" format="ixt:datemonthdayyearen">November 17, 2021</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <div><br /></div>

        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
      </div>


      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_5e4b5ac1e4aa4fcbb0133501b24bd4c1" contextRef="c20211117to20211117">Great Elm Group, Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of Registrant as Specified in Its Charter)</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_c99eae56869e4e0284857ef0675d3c42" contextRef="c20211117to20211117" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
                </div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_90e165dd9f32444badf8ad00ba146131" contextRef="c20211117to20211117">001-39832</ix:nonNumeric><br />
                </div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_90359928a0904e55b0579e08bca08705" contextRef="c20211117to20211117">85-3622015</ix:nonNumeric><br />
                </div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Commission File Number)</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_92d696bfb1c54ded8b9dcacf8eac4ae8" contextRef="c20211117to20211117">800 South Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_1b641dbee1084970bf96bcab19612793" contextRef="c20211117to20211117">Suite 230</ix:nonNumeric>,</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_c58009346e9d4c62afa45ecad77be6ee" contextRef="c20211117to20211117">Waltham</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_2438d2ab36804d28a2ff1952957c3f94">MA</span></div>
              </div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_60175c7b3bc647f39db297459603e1c9" contextRef="c20211117to20211117">02453</ix:nonNumeric><br />
                </div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s Telephone Number, Including Area Code:&#160; <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_25ddd4b00e6246eaa9c5ba670b2f1085" contextRef="c20211117to20211117">617</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_b0e9492ac63541f79fb441de04e3376e" contextRef="c20211117to20211117">375-3006</ix:nonNumeric></span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"> <br />
        </span></div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_1bc6893a6b2747408db4991a7938812f" contextRef="c20211117to20211117" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_9728b49e4ab2427dbfd5ca0579d6ac5b" contextRef="c20211117to20211117" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_5c2351e510514b25bcf3ebc86f29997c" contextRef="c20211117to20211117" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div>
                    <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_f8d474153a054c5b8a8e69987320b388" contextRef="c20211117to20211117" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div>
                    <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Title of each class</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_c0bbe2d30da145858748cc0022c8942d" contextRef="c20211117to20211117">Common stock, par value $0.001 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_645dc4a3f551468eb8b832117b112a4a" contextRef="c20211117to20211117">GEG</ix:nonNumeric><br />
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_00c22ce5c17949ada9d7bb3ba36ec805" contextRef="c20211117to20211117" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
              </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Nasdaq Global Select Market)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule
        12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_30f8e6b63480460ea3e6be79ada37151" contextRef="c20211117to20211117" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><a id="Check5"></a></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#9744;<a id="Check6"></a></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <!--PROfilePageNumberReset%Num%2%- % -%-->
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 67.5pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 17, 2021, Great Elm Group, Inc. (the &#8220;Corporation&#8221;) held its 2021 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;). At the Annual
          Meeting, the stockholders of the Corporation approved the Amendment (the &#8220;Amendment&#8221;) to the Great Elm Group, Inc. Amended and Restated 2016 Long-Term Incentive Compensation Plan (the &#8220;Plan&#8221;) to increase the number of shares of the Corporation&#8217;s
          common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), authorized for issuance thereunder by 2,000,000, effective as of the date of the Annual Meeting. The Plan (reflecting the Amendment) is filed as Exhibit 10.1 to this Current Report on
          Form 8-K and incorporated herein by reference.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.07</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Submission of Matters to a Vote of Security Holders.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On November 17, 2021, the Corporation held the Annual Meeting.&#160; The results of the voting at the Annual Meeting were as follows:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">For</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Against</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Abstain</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-weight: bold;">Broker Non-Votes</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Election of directors:</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Matthew A. Drapkin</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">9,609,514</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">7,695,651</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">539</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Thomas S. Harbin III</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">12,681,224</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">4,623,941</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">539</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">James H. Hugar</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">12,343,337</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">4,961,828</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">539</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">James P. Parmelee</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">10,636,557</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,668,608</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">539</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Peter A. Reed</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">12,799,317</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">4,505,844</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">543</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Jason W. Reese</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">13,258,564</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">4,046,601</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">539</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Eric J. Scheyer</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">12,316,922</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">4,988,239</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">543</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt;">Jeffrey S. Serota</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">10,619,086</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,686,075</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">543</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Approval of the Amendment to the Amended and Restated 2016 Long-Term Incentive Compensation Plan to increase the number of shares of Common Stock authorized for issuance
                thereunder by 2,000,000</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">14,734,890</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">2,566,917</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">3,897</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Ratification of the selection of Grant Thornton LLP to serve as the Corporation&#8217;s independent registered public accounting firm for the fiscal year ending June 30, 2022</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">23,954,828</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">48,110</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">17,114</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">0</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Approval, on a non-binding advisory basis, of the compensation of the Corporation&#8217;s named executive officers</div>
            </td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">9,657,475</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,875,737</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">772,492</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15.79%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">6,714,348</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Financial Statements and Exhibits</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">Exhibit No.</div>
            </td>

    <td style="width: 92%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10030953_ex10-1.htm">10.1</a></div>
            </td>

    <td style="width: 92%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Great Elm Group, Inc. Amended and Restated 2016 Long-Term Incentive Compensation Plan (As Amended, Effective November 17, 2021)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">104</div>
            </td>

    <td style="width: 92%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">The cover page from this Current Report on Form 8-K, formatted as inline XBRL</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">- 2 -</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
        duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">GREAT ELM GROUP, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Date:&#160; November 17, 2021</div>
            </td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid black; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">/s/ Brent J. Pearson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Brent J. Pearson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;">Title:</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

    </div>

    <div style="text-align: center;"> <br />
      <span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">- 3 -</span></div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10030953_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit 10.1</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font></div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">GREAT ELM GROUP, INC.</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AMENDED AND RESTATED</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2016 LONG-TERM INCENTIVE COMPENSATION PLAN</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z087b3ffda2b246b4aa83755cb17e6dc2">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">ESTABLISHMENT; PURPOSES; AND DURATION</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8591f2fd66844515a9f0475071c703b9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Establishment of the Plan.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Plan permits the grant of Non-Qualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares, Cash-Based Awards and
                  Other Stock-Based Awards.&#160; Following adoption of the Plan by the Board of Directors, the Plan shall become effective upon the date on which the Plan is approved by holders of a majority of the Company&#8217;s outstanding shares of common stock,
                  which approval must occur within the period ending twelve months after the date the Plan is adopted by the Board.&#160; The Plan shall remain in effect as provided in Section 1.3.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d6acf6b09044f2aae07f41833497b7c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Purposes of the Plan.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The purposes of the Plan are to provide additional incentives to non-employee directors of the Company and to those officers, employees and consultants of the Company, Subsidiaries and Affiliates whose substantial contributions
                  are essential to the continued growth and success of the business of the Company and the Subsidiaries and Affiliates, in order to strengthen their commitment to the Company and the Subsidiaries and Affiliates, and to attract and retain
                  competent and dedicated individuals whose efforts will result in the long-term growth and profitability of the Company and to further align the interests of such non-employee directors, officers, employees and consultants with the
                  interests of the stockholders of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd79ab03a5f3148aaae5c0921dde9e180">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Duration and Scope of the Plan.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Plan shall commence on the Effective Date, and shall remain in effect, subject to the right of the Board of Directors to amend or terminate the Plan at any time pursuant to Article 14, until all Shares subject to
                  it shall have been delivered, and any restrictions on such Shares have lapsed, pursuant to the Plan&#8217;s provisions.&#160; However, in no event may an Award be granted under the Plan on or after ten years from the Effective Date.&#160; For
                  clarification purposes, the terms and conditions of the Plan, to the extent they differ from the terms and conditions of the Company&#8217;s 2016 Long-Term Incentive Compensation Plan as originally adopted (the &#8220;Prior Plan&#8221;), shall not apply to
                  or otherwise impact previously granted or outstanding awards under the Prior Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbabf6ad25fd5499699e611571070df43">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">ADMINISTRATION</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1297d7d212a4e2bb209f2ce273da769">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">General.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The
                  Committee shall have exclusive authority to operate, manage and administer the Plan in accordance with its terms and conditions.&#160; Notwithstanding the foregoing, in its absolute discretion, the Board may at any time and from time to time
                  exercise any and all rights, duties and responsibilities of the Committee under the Plan, including establishing procedures to be followed by the Committee, but excluding matters which under any applicable law, regulation or rule,
                  including any exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3), are required to be determined in the sole discretion of the Committee.&#160; If and to the extent that the Committee does not exist or cannot function,
                  the Board may take any action under the Plan that would otherwise be the responsibility of the Committee, subject to the limitations set forth in the immediately preceding sentence.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%- % -%-->
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ebeb9a11bcc4ff9b716e113da9b5633">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Committee.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board of Directors.&#160; Appointment of Committee members shall be effective upon their acceptance of such appointment.&#160; Committee
                  members may be removed by the Board at any time either with or without cause, and such members may resign at any time by delivering notice thereof to the Board.&#160; Any vacancy on the Committee, whether due to action of the Board or any
                  other reason, shall be filled by the Board.&#160; A majority of the Committee shall constitute a quorum and a majority of a quorum may authorize any action.&#160; Any decision reduced to writing and signed by a majority of the members of the
                  Committee shall be fully effective as if it has been made at a meeting duly held.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z367ba6747d9844d08ad0de7b94f9d01e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Authority of the Committee.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee shall have full discretionary authority to grant, pursuant to the terms of the Plan, Awards to those individuals who are eligible to receive Awards under the Plan.&#160; Except as limited by law or by the
                  certificate of incorporation or bylaws of the Company, in each case as in effect from time to time, and subject to the provisions herein, the Committee shall have full power, in accordance with the other terms and provisions of the Plan,
                  to:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfbd0fd817217476ba5b73ca940d4cf2a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>select Employees, Non-Employee Directors and Consultants who may receive Awards under the Plan and become Participants;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf25af21e201f401b93da0e737d0f5534">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>determine eligibility for participation in the Plan and decide all questions concerning eligibility for, and the amount of, Awards under the Plan;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z94d8e9e4b564494a820ce66e31dd570e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>determine the sizes and types of Awards;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96c8b960e203482e99f89df6e1f9827e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>determine the terms and conditions of Awards, including the Option Prices of Options and the Grant Prices of SARs;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc0589cdd0f24ab3af9149f91b71ff9a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>grant Awards as an alternative to, or as the form of payment for grants or rights earned or payable under, other bonus or compensation plans, arrangements or policies of the Company or a Subsidiary or Affiliate;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4f40fbba6d54bb99e67220706da9e6c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>grant Substitute Awards on such terms and conditions as the Committee may prescribe, subject to compliance with the ISO rules under Code Section 422 and the non-qualified deferred compensation rules under Code Section 409A, where
                applicable;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9fb33a3c8a5a4a54a4d69301c8e07f18">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>make all determinations under the Plan concerning Termination of any Participant&#8217;s employment or service with the Company or a Subsidiary or Affiliate, including whether such Termination occurs by reason of Cause, Good Reason,
                disability, retirement or in connection with a Change of Control and whether a leave constitutes a Termination;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc53fb3ef7fec41e7bc52667df53a185e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>construe and interpret the Plan and any agreement or instrument entered into under the Plan, including any Award Agreement;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 2 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcced4a0ce6ca468f8665f4a22139796d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>establish and administer any terms, conditions, restrictions, limitations, forfeiture, vesting or exercise schedule, and other provisions of or relating to any Award;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd698b78d702349df95f7c916287be949">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(j)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>establish and administer any performance goals in connection with any Awards, including performance criteria and applicable Performance Periods, determine the extent to which any performance goals and/or other terms and conditions of an
                Award are attained or are not attained;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z520e2553f1b34ffda9e5ef6371845d45">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(k)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>construe any ambiguous provisions, correct any defects, supply any omissions and reconcile any inconsistencies in the Plan and/or any Award Agreement or any other instrument relating to any Awards;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcaa7e6745db64dc78a9d7fea18f4316d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(l)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>establish, adopt, amend, waive and/or rescind rules, regulations, procedures, guidelines, forms and/or instruments for the Plan&#8217;s operation or administration;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z51d240c5494d4fd7a4eecbfc59abfb5e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(m)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>make all valuation determinations relating to Awards and the payment or settlement thereof;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe90d9918d8946219aa4251a587ad270">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(n)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>grant waivers of terms, conditions, restrictions and limitations under the Plan or applicable to any Award, or accelerate the vesting or exercisability of any Award;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4880e5821fb74bc48e3ada479081f463">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(o)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>subject to the provisions of Article 14, amend or adjust the terms and conditions of any outstanding Award and/or adjust the number and/or class of shares of stock subject to any outstanding Award;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze95b2867a0c745a4b69bb1b8774271bc">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(p)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>at any time and from time to time after the granting of an Award, specify such additional terms, conditions and restrictions with respect to such Award as may be deemed necessary or appropriate to ensure compliance with any and all
                applicable laws or rules, including terms, restrictions and conditions for compliance with applicable securities laws or listing rules, methods of withholding or providing for the payment of required taxes and restrictions regarding a
                Participant&#8217;s ability to exercise Options through a cashless (broker-assisted) exercise;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e41eb155a8b4f1da77cf87cce633f58">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(q)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>subject to Section 13.1, offer to buy out an Award previously granted, based on such terms and conditions as the Committee shall establish with and communicate to the Participant at the time such offer is made;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80c74a3d771943b69f4d75a7be9f6a06">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(r)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>determine whether, and to what extent and under what circumstances Awards may be settled in cash, Shares or other property or canceled or suspended; and</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z045ba659e9fb4cad8dfa888061a76cca">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(s)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>exercise all such other authorities, take all such other actions and make all such other determinations as it deems necessary or advisable for the proper operation and/or administration of the Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 3 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fc9449b6303410aa16563a0c4a2550d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Award Agreements.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee shall, subject to applicable laws and rules, determine the date an Award is granted.&#160; Each Award shall be evidenced by an Award Agreement; however, two or more Awards granted to a single Participant may be combined
                  in a single Award Agreement.&#160; An Award Agreement shall not be a precondition to the granting of an Award; <font style="font-style: italic;">provided, however</font>, that (a) the Committee may, but need not, require as a condition to any
                  Award Agreement&#8217;s effectiveness, that such Award Agreement be executed on behalf of the Company and/or by the Participant to whom the Award evidenced thereby shall have been granted (including by electronic signature or other electronic
                  indication of acceptance), and such executed Award Agreement be delivered to the Company, and (b) no person shall have any rights under any Award unless and until the Participant to whom such Award shall have been granted has complied
                  with the applicable terms and conditions of the Award.&#160; The Committee shall prescribe the form of all Award Agreements, and, subject to the terms and conditions of the Plan, shall determine the content of all Award Agreements.&#160; In the
                  event of any dispute or discrepancy concerning the terms of an Award, the records of the Committee or its designee shall be determinative.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za4be68719f30420eafbec946293013d8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Discretionary Authority; Decisions Binding.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee shall have full discretionary authority in all matters related to the discharge of its responsibilities and the exercise of its authority under the Plan.&#160; All determinations, decisions,
                  actions and interpretations by the Committee with respect to the Plan and any Award Agreement, and all related orders and resolutions of the Committee shall be final, conclusive and binding on all Participants, the Company and its
                  stockholders, any Subsidiary or Affiliate and all persons having or claiming to have any right or interest in or under the Plan and/or any Award Agreement.&#160; The Committee shall consider such factors as it deems relevant to making or
                  taking such decisions, determinations, actions and interpretations, including the recommendations or advice of any Director or officer or employee of the Company, any director, officer or employee of a Subsidiary or Affiliate and such
                  attorneys, consultants and accountants as the Committee may select.&#160; A Participant or other holder of an Award may contest a decision or action by the Committee with respect to such person or Award only on the grounds that such decision
                  or action was arbitrary or capricious or was unlawful, and any review of such decision or action shall be limited to determining whether the Committee&#8217;s decision or action was arbitrary or capricious or was unlawful.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z26c91c4d62cf4860a28c3ff0d0e49452">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Delegation of Administration.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except to the extent prohibited by applicable law, including any applicable exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3), or the applicable rules of a stock exchange, the Committee may, in
                  its discretion, allocate all or any portion of its responsibilities and powers under this Article 2 to any one or more of its members and/or delegate all or any part of its responsibilities and powers under this Article 2 to any person or
                  persons selected by it; <font style="font-style: italic;">provided,</font> however, that the Committee may not (a) delegate to any executive officer of the Company or an Affiliate, or a committee that includes any such executive officer,
                  the Committee&#8217;s authority to grant Awards, or the Committee&#8217;s authority otherwise concerning Awards, awarded to executive officers of the Company or an Affiliate; (b) delegate the Committee&#8217;s authority to grant Awards to consultants
                  unless any such Award is subject to approval by the Committee; (c) delegate its authority to correct defects, omissions or inconsistencies in the Plan; or (d) delegate its authority with respect to Awards that are intended to qualify as
                  performance-based compensation under Code Section 162(m) if such delegation would cause the Awards to fail to so qualify.&#160; Any such authority delegated or allocated by the Committee under this Section 2.6 shall be exercised in accordance
                  with the terms and conditions of the Plan and any rules, regulations or administrative guidelines that may from time to time be established by the Committee, and any such allocation or delegation may be revoked by the Committee at any
                  time.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 4 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc1f15092a78945229ac83fd78fe3f874">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">SHARES SUBJECT TO THE PLAN</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z16e7ca9027a7471cae8ca32f9b2a4215">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Number of Shares Available for Grants.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The shares of stock subject to Awards granted under the Plan shall be Shares.&#160; Such Shares subject to the Plan may be either authorized and unissued shares or previously issued shares acquired by the Company or
                  any Subsidiary.&#160; As of the Effective Date, 6,050,000 Shares are reserved for issuance of Awards, subject to adjustment as provided in Section 3.2.&#160; Subject to, in the case of ISOs, any limitations applicable thereto under the Code, if (a)
                  any Shares are subject to an Option, SAR, or other Award which for any reason expires or is terminated or canceled without having been fully exercised or satisfied, or are subject to any Restricted Stock Award (including any Shares
                  subject to a Participant&#8217;s Restricted Stock Award that are repurchased by the Company at the Participant&#8217;s cost), Restricted Stock Unit Award or other Award granted under the Plan which are forfeited, or (b) any Award based on Shares is
                  settled for cash, expires or otherwise terminates without the issuance of such Shares, the Shares subject to such Award shall, to the extent of any such expiration, termination, cancellation, forfeiture or cash settlement, be available
                  for delivery in connection with future Awards under the Plan.&#160; Any Shares delivered under the Plan upon exercise or satisfaction of Substitute Awards shall not reduce the Shares available for delivery under the Plan; <font style="font-style: italic;">provided, however</font>, that the total number of Shares that may be delivered pursuant to Incentive Stock Options granted under the Plan shall be the number of Shares set forth in the third sentence of this
                  Section 3.1, as adjusted pursuant to this Section 3.1, but without application of the foregoing provisions of this sentence.&#160; Shares may be issued under the terms of this Plan in connection with a merger or acquisition as permitted by
                  NASDAQ Listing Rule 5635(c), NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of Shares available for issuance under the Plan.&#160; The payment
                  of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not be counted against the shares available for issuance under the Plan.&#160; Notwithstanding anything to the contrary contained herein, the following Shares
                  will not be added to the aggregate number of Shares available for issuance of Awards under this <u>Section 3.1</u>: (a) Shares withheld by the Company, tendered or otherwise used in payment of the Option Price of an Option, (b) Shares
                  withheld or otherwise used by the Company to satisfy a tax withholding obligation, (c) Shares subject to a SAR that are not actually issued in connection with the settlement thereof, and (d) Shares reacquired by the Company on the open
                  market or otherwise using cash proceeds from the exercise of Options.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 5 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91373103468d4f5fa2b207747da888bc">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjustments in Authorized Shares.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; In the event of any corporate event or transaction (including a change in the Shares or the capitalization of the Company), such as a reclassification, recapitalization, merger, consolidation, reorganization (whether
                  or not such reorganization comes within the definition of such term in Code Section 368), issuance of warrants or rights, dividend or other distribution (whether in the form of cash, stock or other property), stock split or reverse stock
                  split, spin-off, split-up, combination or exchange of shares, repurchase of shares, or other like change in corporate structure, partial or complete liquidation of the Company or distribution (other than normal cash dividends) to
                  stockholders of the Company, or any similar corporate event or transaction, the Committee shall substitute or adjust, as applicable, the number, class and kind of securities which may be delivered under Section 3.1; the number, class and
                  kind, and/or price (such as the Option Price of Options or the Grant Price of SARs) of securities subject to outstanding Awards; the numerical limits set forth in Section 4.3; and other value determinations applicable to outstanding
                  Awards, in order to prevent dilution or enlargement of Participants&#8217; rights under the Plan; provided, however, that the number of Shares subject to any Award shall always be a whole number.&#160; The Committee shall also make appropriate
                  adjustments and modifications in the terms of any outstanding Awards to reflect or related to any such events, adjustments, substitutions or changes.&#160; Any adjustment, substitution or change pursuant to this Section 3.2 made with respect
                  to an Award intended to be an Incentive Stock Option shall be made only to the extent consistent with such intent, unless the Committee determines otherwise.&#160; The Committee shall not make any adjustment pursuant to this Section 3.2 that
                  would cause an Award that is otherwise exempt from Code Section 409A to become subject to Code Section 409A, or that would cause an Award that is subject to Code Section 409A to fail to satisfy the requirements of Code Section 409A.&#160; All
                  determinations of the Committee as to adjustments or changes, if any, under this Section 3.2 shall be conclusive and binding on the Participants.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z952a1005e0204ea5842eee0bf322f46d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Limitation on Corporate Actions.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The existence of the Plan and any Awards granted hereunder shall not affect in any way the right or power of the Company, any Subsidiary or any Affiliate to make or authorize any adjustment, recapitalization,
                  reorganization or other change in its capital structure or business structure, any merger or consolidation, any issuance of debt, preferred or prior preference stock ahead of or affecting the Shares, additional shares of capital stock or
                  other securities or subscription rights thereto, any dissolution or liquidation, any sale or transfer of all or part of its assets or business or any other corporate act or proceeding.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze806d1d702bd432bb6868d6508f1abc9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">ELIGIBILITY, PARTICIPATION AND INDIVIDUAL LIMITATIONS ON AWARDS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z087fb45a100e44a0a28250807334ed72">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Eligibility.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Employees, Non-Employee Directors and Consultants shall be eligible to become Participants and receive Awards in accordance with the terms and conditions of the Plan, subject to the limitations on the granting of ISOs set forth in Section
                  6.8(a).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeaf05671d19e483ab01f9d74959c4947">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Actual Participation.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the provisions of the Plan, the Committee may, from time to time, select Participants from all eligible Employees, Non-Employee Directors and Consultants and shall determine the nature and amount of each Award.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4dfbd6189aab42c09e3463223a1499a0">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Individual Limitations on Awards.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 6 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55891ac3786a4a268daef3d69f118bc9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Individual Limit for Options and SARs</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; The maximum number of Shares with respect to which Options and SARs may be granted to any Participant in any Fiscal Year shall be 1 million.&#160; In connection with a Participant&#8217;s commencement of service for the Company,
                  any Affiliate or Subsidiary, as applicable, a Participant may be granted Options and SARs for up to an additional 3 million Shares which shall not count against the limit set forth in the previous sentence.&#160; The foregoing limitation(s)
                  shall be adjusted proportionately in connection with any change in the Company&#8217;s capitalization pursuant to Section 4.2.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z570b215fbc44470c857ff74e6b4ada94">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Individual Limit for Awards to Non-Employee Directors</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; The maximum grant date fair value, determined in accordance with the Company&#8217;s standard accounting principles, of Awards that may be granted to any Non-Employee Director in any Fiscal Year together with any
                  cash compensation payable to such Non-Employee Director for such Fiscal Year shall be $500,000.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za34111507b33469790e96ad739d4b676">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">STOCK OPTIONS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2b0df7b58134d6d9897f7f2190c409b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Grant of Options.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the terms and provisions of the Plan, Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ca60f281a9f45d69cf7e2c6e75aad9d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Award Agreement.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the maximum duration of the Option, the number of Shares to which the Option pertains, the conditions upon which the Option shall
                  become exercisable and such other provisions as the Committee shall determine, which are not inconsistent with the terms of the Plan.&#160; The Award Agreement also shall specify whether the Option is intended to be an ISO or an NQSO.&#160; To the
                  extent that any Option does not qualify as an ISO (whether because of its provisions or the time or manner of its exercise or otherwise), such Option, or the portion thereof which does not so qualify, shall constitute a separate NQSO.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3c3bf45333f84a57bb5eaaaa332b164d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Option Price.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The Option Price for each Option shall be determined by the Committee and set forth in the Award Agreement; <font style="font-style: italic;">provided</font> that, subject to Section 5.8(c), the Option Price of an Option shall be not
                  less than one hundred percent of the Fair Market Value of a Share on the date the Option is granted; <font style="font-style: italic;">provided further</font>, that Substitute Awards or Awards granted in connection with an adjustment
                  provided for in Section 3.2, in the form of stock options, shall have an Option Price per Share that is intended to maintain the economic value of the Award that was replaced or adjusted, as determined by the Committee.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z209959f2d0d4435cb7b0e59092e027c8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Duration of Options.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Option granted to a Participant shall expire at such time as the Committee shall determine at the time of grant and set forth in the Award Agreement; provided, however, that no Option shall be exercisable later than the
                  tenth anniversary of its date of grant, subject to the respective last sentences of Sections 5.5 and 5.8(c).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd207f5c6f1c54bce80c70238a8613918">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">EXERCISE OF OPTIONS.<a name="start"></a></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 7 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c60e39d39af47408bb9ab26ddc10e52">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Options shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance determine and set forth in the Award Agreement, which need not be the same for each grant or for each
                Option or Participant.&#160; An Award Agreement may provide that the period of time over which an Option other than an ISO may be exercised shall be automatically extended if on the scheduled expiration date of such Option the Participant&#8217;s
                exercise of such Option would violate applicable securities laws; <font style="font-style: italic;">provided</font>, however, that during such extended exercise period the Option may only be exercised to the extent the Option was
                exercisable in accordance with its terms immediately prior to such scheduled expiration date; <font style="font-style: italic;">provided further</font>, however, that such extended exercise period shall end not later than thirty days after
                the exercise of such Option first would no longer violate such laws.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaa2329f790c442b181bfd98a0e616668">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Committee may provide that unvested Options can be exercised by payment of the exercise price thereof to the Company.&#160; The Company or an escrow agent appointed by the Company shall hold any Shares acquired upon exercise of an
                unvested Option.&#160; Such Shares shall be released from escrow if, as, when and to the extent the vesting and performance (if any) criteria of such option are satisfied.&#160; To the extent the vesting and performance criteria (if any) of such
                Option are not satisfied, (i) the Participant shall not have the right to refund of any exercise price paid in respect of such Option and (ii) the shares issued upon exercise of such unvested Option shall be returned to the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z59bc0057694a4a9cbf507120c5300d3c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Payment.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Options shall be exercised by the delivery of a written notice of exercise to the Company, in a form specified or accepted by the Committee, or by complying with any alternative exercise procedures that may be authorized by the Committee,
                  setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for such Shares, which shall include applicable taxes, if any, in accordance with Article 14.&#160; The Option Price upon
                  exercise of any Option shall be payable to the Company in full either: (a) in cash or its equivalent; (b) subject to such terms, conditions and limitations as the Committee may prescribe, by tendering (either by actual delivery or
                  attestation) unencumbered Shares previously acquired by the Participant exercising such Option having an aggregate Fair Market Value at the time of exercise equal to the total Option Price, (c) by a combination of (a) and (b); or (d) by
                  any other method approved or accepted by the Committee in its sole discretion, including, if the Committee so determines, (x) a cashless (broker-assisted) exercise that complies with all applicable laws or (y) withholding of Shares
                  otherwise deliverable to the Participant pursuant to the Option having an aggregate Fair Market Value at the time of exercise equal to the total Option Price.&#160; Subject to any governing rules or regulations, as soon as practicable after
                  receipt of a written notification of exercise and full payment in accordance with the preceding provisions of this Section 5.6, the Company shall deliver to the Participant exercising an Option, in the Participant&#8217;s name, evidence of book
                  entry Shares, or, upon the Participant&#8217;s request, Share certificates, in an appropriate amount based upon the number of Shares purchased under the Option, subject to Section 18.10.&#160; Unless otherwise determined by the Committee, all
                  payments under all of the methods described above shall be paid in United States dollars.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2cd1483a100a464d8865610d48f5d6a9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Termination of Employment or Service.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except as otherwise provided in the Award Agreement, an Option may be exercised only to the extent that it is then exercisable, and if at all times during the period beginning with the date of granting of such
                  Option and ending on the date of exercise of such Option the Participant is an Employee, Non-Employee Director or Consultant, and shall terminate immediately upon a Termination of the Participant.&#160; An Option shall cease to become
                  exercisable upon a Termination of the holder thereof.&#160; Notwithstanding the foregoing provisions of this Section 5.7 to the contrary, the Committee may determine in its discretion that an Option may be exercised following any such
                  Termination, whether or not exercisable at the time of such Termination; <font style="font-style: italic;">provided</font>, however, that in no event may an Option be exercised after the expiration date of such Option specified in the
                  applicable Award Agreement, except as provided in the last sentence of Section 5.5.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 8 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z75d144aeb02e47dfb1fded65cdd3585a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">LIMITATIONS ON INCENTIVE STOCK OPTIONS.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z62fc54f8036047ee9331538a0c4821f7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; No ISO shall be
                  granted to any individual otherwise eligible to participate in the Plan who is not an Employee of the Company or a Subsidiary on the date of granting of such Option.&#160; Any ISO granted under the Plan shall contain such terms and conditions,
                  consistent with the Plan, as the Committee may determine to be necessary to qualify such Option as an &#8220;incentive stock option&#8221; under Code Section 422.&#160; Any ISO granted under the Plan may be modified by the Committee to disqualify such
                  Option from treatment as an &#8220;incentive stock option&#8221; under Code Section 422.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a59bae13dd647ea98c9fe0ca1181c91">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>$100,000 Per Year Limitation</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; Notwithstanding any intent to grant ISOs, an Option granted under the Plan will not be considered an ISO to the extent that it, together with any other &#8220;incentive stock options&#8221; (within the meaning of Code Section 422, but
                  without regard to subsection (d) of such Section) under the Plan and any other &#8220;incentive stock option&#8221; plans of the Company, any Subsidiary and any &#8220;parent corporation&#8221; of the Company within the meaning of Code Section 424(e), are
                  exercisable for the first time by any Participant during any calendar year with respect to Shares having an aggregate Fair Market Value in excess of $100,000 (or such other limit as may be required by the Code) as of the time the Option
                  with respect to such Shares is granted.&#160; The rule set forth in the preceding sentence shall be applied by taking Options into account in the order in which they were granted.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8167b3f786854ae393f5a170fa1e26be">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Options Granted to Certain Stockholders</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; No ISO shall be granted to an individual otherwise eligible to participate in the Plan who owns (within the meaning of Code Section 424(d)), at the time the Option is granted, more than ten percent of the total
                  combined voting power of all classes of stock of the Company or a Subsidiary or any &#8220;parent corporation&#8221; of the Company within the meaning of Section 424(e) of the Code.&#160; This restriction does not apply if at the time such ISO is granted
                  the Option Price of the ISO is at least one hundred ten percent of the Fair Market Value of a Share on the date such ISO is granted, and the ISO by its terms is not exercisable after the expiration of five years from such date of grant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7c08342a4e104f938d6338d43ee0842a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Substitution of Stock Appreciation Rights.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the other provisions of this Plan, the Committee may provide in the Award Agreement evidencing the grant of an Option that the Committee, in its sole discretion, shall have to right to substitute
                  a SAR for such Option at any time prior to or upon exercise of such Option; <font style="font-style: italic;">provided</font>, that such SAR shall be exercisable with respect to the same number of shares of Stock for which such
                  substituted Option would have been exercisable.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 9 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14f14f0d96b845038068bbe1a4aa3024">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">STOCK APPRECIATION RIGHTS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe0123bb334d4f00bd4df5bc1f4e69cd">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Grant of SARs.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Subject to the terms and conditions of the Plan, SARs may be granted to Participants at any time and from time to time as shall be determined by the Committee.&#160; The Committee may grant an SAR (a) in connection and simultaneously with the
                  grant of an Option (a Tandem SAR) or (b) independent of, and unrelated to, an Option (a Freestanding SAR).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z52c00dd0dd064d998ec00cabdb6c253d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Grant Price.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The Grant Price for each SAR shall be determined by the Committee and set forth in the Award Agreement, subject to the limitations of this Section 6.2.&#160; The Grant Price for each Freestanding SAR shall be not less than one hundred percent
                  of the Fair Market Value of a Share on the date such Freestanding SAR is granted, except in the case of Substitute Awards or Awards granted in connection with an adjustment provided for in Section 3.2.&#160; The Grant Price of a Tandem SAR
                  shall be equal to the Option Price of the related Option.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zca1088052e6d489190680042cdd58dfb">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise of Tandem SARs.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Tandem SARs may be exercised for all or part of the Shares subject to the related Option upon the surrender of the right to exercise the equivalent portion of the related Option.&#160; A Tandem SAR shall be exercisable only
                  when and to the extent the related Option is exercisable and may be exercised only with respect to the Shares for which the related Option is then exercisable.&#160; A Tandem SAR shall entitle a Participant to elect, in the manner set forth in
                  the Plan and the applicable Award Agreement, in lieu of exercising his or her unexercised related Option for all or a portion of the Shares for which such Option is then exercisable pursuant to its terms, to surrender such Option to the
                  Company with respect to any or all of such Shares and to receive from the Company in exchange therefor a payment described in Section 6.7.&#160; An Option with respect to which a Participant has elected to exercise a Tandem SAR shall, to the
                  extent of the Shares covered by such exercise, be canceled automatically and surrendered to the Company.&#160; Such Option shall thereafter remain exercisable according to its terms only with respect to the number of Shares as to which it
                  would otherwise be exercisable, less the number of Shares with respect to which such Tandem SAR has been so exercised.&#160; Notwithstanding any other provision of the Plan to the contrary, with respect to a Tandem SAR granted in connection
                  with an ISO: (a) the Tandem SAR will expire no later than the expiration of the related ISO; (b) the value of the payment with respect to the Tandem SAR may not exceed the difference between the Fair Market Value of the Shares subject to
                  the related ISO at the time the Tandem SAR is exercised and the Option Price of the related ISO; and (c) the Tandem SAR may be exercised only when the Fair Market Value of the Shares subject to the ISO exceeds the Option Price of the ISO.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81456a530ad44a32b17b4b1792cbea4e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise of Freestanding SARs.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Freestanding SARs may be exercised upon whatever terms and conditions the Committee, in its sole discretion, in accordance with the Plan, determines and sets forth in the Award Agreement.&#160; An Award Agreement may
                  provide that the period of time over which a Freestanding SAR may be exercised shall be automatically extended if on the scheduled expiration date of such SAR the Participant&#8217;s exercise of such SAR would violate applicable securities
                  laws; <font style="font-style: italic;">provided</font>, however, that during such extended exercise period the SAR may only be exercised to the extent the SAR was exercisable in accordance with its terms immediately prior to such
                  scheduled expiration date; <font style="font-style: italic;">provided further</font>, however, that such extended exercise period shall end not later than thirty days after the exercise of such SAR first would no longer violate such
                  laws.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 10 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a80b9e4b7404ac28ba02f95ef6eff78">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Award Agreement.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each SAR grant shall be evidenced by an Award Agreement that shall specify the number of Shares to which the SAR pertains, the Grant Price, the term of the SAR, and such other terms and conditions as the Committee shall determine
                  in accordance with the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e5b8345756e4ee19e5e0e346c4ebe90">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Term of SARs.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The term of a SAR granted under the Plan shall be determined by the Committee, in its sole discretion; <font style="font-style: italic;">provided</font>, however, that the term of any Tandem SAR shall be the same as the related Option
                  and no SAR shall be exercisable more than ten years after it is granted, subject to the last sentence of Section 5.5(a) in the case of a Tandem SAR.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79c9b86b66394e068bbe507e49dcbc76">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Payment of SAR Amount.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; An election to exercise SARs shall be deemed to have been made on the date of Notice of such election to the Company.&#160; As soon as practicable following such Notice, the Participant shall be entitled to receive payment from the
                  Company in an amount determined by multiplying:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9e8cebdc3394405a5f93d787b104713">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The excess of the Fair Market Value of a Share on the date of exercise over the Grant Price of the SAR; by</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z905454a34b9f495393197db1a32d96df">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The number of Shares with respect to which the SAR is exercised.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9d4f59dec4ac4a1bbb51b993f9225d1c" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing provisions of this Section 6.7 to the contrary, the Committee may establish and set forth in the applicable Award Agreement a
                  maximum amount per Share that will be payable upon the exercise of a SAR.&#160; At the discretion of the Committee, such payment upon exercise of a SAR shall be in cash, in Shares of equivalent Fair Market Value, or in some combination
                  thereof.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za6ce7c0ca1924a4caf58f5a0ca1c0070">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Termination of Employment or Service.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except as otherwise provided in the Award Agreement, a SAR may be exercised only to the extent that it is then exercisable, and if at all times during the period beginning with the date of granting of such SAR
                  and ending on the date of exercise of such SAR the Participant is an Employee, Non-Employee Director or Consultant, and shall terminate immediately upon a Termination of the Participant.&#160; A SAR shall cease to become exercisable upon a
                  Termination of the holder thereof.&#160; Notwithstanding the foregoing provisions of this Section 6.8 to the contrary, the Committee may determine in its discretion that a SAR may be exercised following any such Termination, whether or not
                  exercisable at the time of such Termination; provided, however, that in no event may a SAR be exercised after the expiration date of such SAR specified in the applicable Award Agreement, except as provided in the last sentence of Section
                  5.5(a) (in the case of Tandem SARs) or in the last sentence of Section 6.4 (in the case of Freestanding SARs).&#160; To the extent applicable to any Tandem SAR, the foregoing provisions of this Section 6.8 are subject to the provisions of
                  Section 6.8, pursuant to the provisions Section 6.3.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 11 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z877c091a718f4ce9bc7fe1e483c53207">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">RESTRICTED STOCK AND RESTRICTED STOCK UNITS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9eca0f42385b496a841ea3261ac14807">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Awards of Restricted Stock and Restricted Stock Units.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the terms and provisions of the Plan, the Committee, at any time and from time to time, may grant Shares of Restricted Stock and/or Restricted Stock Units to
                  Participants in such amounts as the Committee shall determine.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z545a9bd2f27f4a1bbb927aaaf50c3679">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Award Agreement.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Restricted Stock and/or Restricted Stock Unit Award shall be evidenced by an Award Agreement that shall specify the Period of Restriction, the number of Shares of Restricted Stock or the number of Restricted Stock Units
                  granted, and such other provisions as the Committee shall determine in accordance with the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9579a57ed4fe48cd88ce0b6c05cbc49e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Non-Transferability of Restricted Stock.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except as provided in this Article 7, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, encumbered, alienated, hypothecated or otherwise disposed of until the end of the applicable
                  Period of Restriction established by the Committee and specified in the Restricted Stock Award Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbca9cf7f1f354d34ba15b4eabcbaaba7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Period of Restriction and Other Restrictions.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Period of Restriction shall lapse based on continuing service as a Non-Employee Director or Consultant or continuing employment with the Company, a Subsidiary or an Affiliate, the achievement of
                  performance goals, the satisfaction of other conditions or restrictions or upon the occurrence of other events, in each case, as determined by the Committee, at its discretion, and stated in the Award Agreement.&#160; If the grants of
                  Restricted Stock or Restricted Stock Units are intended to qualify as &#8220;performance-based compensation&#8221; under Code Section 162(m), the Committee will set restrictions based upon the achievement of the performance goals set forth in Section
                  8.3 and will determine achievement of such goals in accordance with Section 8.3.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf968c8cf5e6f41a49872f9a5c57c9168">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Delivery of Shares, Payment of Restricted Stock Units.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to Section 18.10, after the last day of the Period of Restriction applicable to a Participant&#8217;s Shares of Restricted Stock, and after all conditions and restrictions
                  applicable to such Shares of Restricted Stock have been satisfied or lapse (including satisfaction of any applicable withholding tax obligations), pursuant to the applicable Award Agreement, such Shares of Restricted Stock shall become
                  freely transferable by such Participant.&#160; After the last day of the Period of Restriction applicable to a Participant&#8217;s Restricted Stock Units, and after all conditions and restrictions applicable to Restricted Stock Units have been
                  satisfied or lapse (including satisfaction of any applicable withholding tax obligations), pursuant to the applicable Award Agreement, such Restricted Stock Units shall be settled by delivery of Shares, a cash payment determined by
                  reference to the then-current Fair Market Value of Shares or a combination of Shares and such cash payment as the Committee, in its sole discretion, shall determine, either by the terms of the Award Agreement or otherwise.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 12 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f7e5b133d7f4a38b49e5470b3a259e1">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Forms of Restricted Stock Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Participant who receives an Award of Shares of Restricted Stock shall be issued a stock certificate or certificates evidencing the Shares covered by such Award registered in the name of such Participant, which
                  certificate or certificates may contain an appropriate legend.&#160; The Committee may require a Participant who receives a certificate or certificates evidencing a Restricted Stock Award to immediately deposit such certificate or
                  certificates, together with a stock power or other appropriate instrument of transfer, endorsed in blank by the Participant, with signatures guaranteed in accordance with the Exchange Act if required by the Committee, with the Secretary
                  of the Company or an escrow holder as provided in the immediately following sentence.&#160; The Secretary of the Company or such escrow holder as the Committee may appoint shall retain physical custody of each certificate representing a
                  Restricted Stock Award until the Period of Restriction and any other restrictions imposed by the Committee or under the Award Agreement with respect to the Shares evidenced by such certificate expire or shall have been removed.&#160; The
                  foregoing to the contrary notwithstanding, the Committee may, in its discretion, provide that a Participant&#8217;s ownership of Shares of Restricted Stock prior to the lapse of the Period of Restriction or any other applicable restrictions
                  shall, in lieu of such certificates, be evidenced by a &#8220;book entry&#8221; (i.e., a computerized or manual entry) in the records of the Company or its designated agent in the name of the Participant who has received such Award.&#160; Such records of
                  the Company or such agent shall, absent manifest error, be binding on all Participants who receive Restricted Stock Awards evidenced in such manner.&#160; The holding of Shares of Restricted Stock by the Company or such an escrow holder, or
                  the use of book entries to evidence the ownership of Shares of Restricted Stock, in accordance with this Section 7.6, shall not affect the rights of Participants as owners of the Shares of Restricted Stock awarded to them, nor affect the
                  restrictions applicable to such shares under the Award Agreement or the Plan, including the Period of Restriction.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6637a70eab454dd483dafa650c7fc6aa">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Voting Rights.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Unless otherwise determined by the Committee and set forth in a Participant&#8217;s Award Agreement, to the extent permitted or required by law, as determined by the Committee, Participants holding Shares of Restricted Stock shall be granted
                  the right to exercise full voting rights with respect to those Shares during the Period of Restriction.&#160; A Participant shall have no voting rights with respect to any Restricted Stock Units.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z580bc7ff2d534f849ae6497afe2e32d1">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Dividends and Other Distributions.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; During the Period of Restriction, Participants holding Shares of Restricted Stock shall be credited with any cash dividends paid with respect to such Shares while they are so held, unless determined otherwise
                  by the Committee and set forth in the Award Agreement.&#160; The Committee may apply any restrictions to such dividends that the Committee deems appropriate.&#160; Except as set forth in the Award Agreement, in the event of (a) any adjustment as
                  provided in Section 3.2, or (b) any shares or securities are received as a dividend, or an extraordinary dividend is paid in cash, on Shares of Restricted Stock, any new or additional Shares or securities or any extraordinary dividends
                  paid in cash received by a recipient of Restricted Stock shall be subject to the same terms and conditions, including the Period of Restriction, as it relates to the original Shares of Restricted Stock.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 13 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6d1a5e5612e460ead4421ea0e751015">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Termination of Employment or Service.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except as otherwise provided in this Section 7.9, during the Period of Restriction, any Restricted Stock Units and/or Shares of Restricted Stock held by a Participant shall be forfeited and revert to the
                  Company (or, if Shares of Restricted Sock were sold to the Participant, the Participant shall be required to resell such Shares to the Company at cost) upon the Participant&#8217;s Termination or the failure to meet or satisfy any applicable
                  performance goals or other terms, conditions and restrictions to the extent set forth in the applicable Award Agreement.&#160; Each applicable Award Agreement shall set forth the extent to which, if any, the Participant shall have the right to
                  retain Restricted Stock Units and/or Shares of Restricted Stock, then subject to the Period of Restriction, following such Participant&#8217;s Termination.&#160; Such provisions shall be determined in the sole discretion of the Committee, shall be
                  included in the applicable Award Agreement, need not be uniform among all such Awards issued pursuant to the Plan, and may reflect distinctions based on the reasons for, or circumstances of, such Termination.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7d7d4a54b514addb28c01edc001b79b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7.10</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Repurchase or Forfeiture of Restricted Stock.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; If no price was paid by the Participant for the Restricted Stock, upon a the Participant&#8217;s Termination, the Participant&#8217;s rights in unvested Restricted Stock then subject to restrictions shall lapse, and
                  such Restricted Stock shall be surrendered to the Company without consideration.&#160; If a price was paid by the Participant for the Restricted Stock, upon the Participant&#8217;s Termination the Company shall have the right to repurchase from the
                  Participant the unvested Restricted Stock then subject to restrictions at a cash price per share equal to the price paid by the Participant for such Restricted Stock or such other amount as may be specified in the Award Agreement.&#160; The
                  Committee in its discretion may provide that in the event of certain events, including a Change in Control, the Participant&#8217;s death, retirement or disability or any other specified Termination of Service or any other event, the
                  Participant&#8217;s rights in unvested Restricted Stock shall not lapse, such Restricted Stock shall vest and, if applicable, the Company shall not have a right of repurchase.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc60225a3b219460080ff393a3438d3fb">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">PERFORMANCE UNITS, PERFORMANCE SHARES, AND CASH-BASED AWARDS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc11c70a808eb4a2ebf603a3ca760051c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Grant of Performance Units, Performance Shares and Cash-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the terms of the Plan, Performance Units, Performance Shares, and/or Cash-Based Awards may be granted to Participants in such amounts and upon such terms, and at any
                  time and from time to time, as shall be determined by the Committee, in accordance with the Plan.&#160; A Performance Unit, Performance Share or Cash-Based Award entitles the Participant who receives such Award to receive Shares or cash upon
                  the attainment of performance goals and/or satisfaction of other terms and conditions determined by the Committee when the Award is granted and set forth in the Award Agreement.&#160; Such entitlements of a Participant with respect to his or
                  her outstanding Performance Unit, Performance Share or Cash-Based Award shall be reflected by a bookkeeping entry in the records of the Company, unless otherwise provided by the Award Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcad2b15b64f8467b8abe867e3079ca06">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Value of Performance Units, Performance Shares and Cash-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Performance Unit shall have an initial value that is established by the Committee at the time of grant.&#160; Each Performance Share shall have an initial value equal to the Fair
                  Market Value of a Share on the date of grant.&#160; Each Cash-Based Award shall have a value as shall be determined by the Committee.&#160; The Committee shall set performance goals in its discretion which, depending on the extent to which they are
                  met, will determine the number and/or value of Performance Units and Performance Shares and Cash-Based Awards that will be paid out to the Participant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 14 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcfcd4627754f4c3c8cac37a2965d28bc">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Earning of Performance Units, Performance Shares and Cash-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the terms of the Plan, after the applicable Performance Period has ended, the holder of Performance Units, Performance Shares or Cash-Based Awards shall be entitled to
                  receive payment on the number and value of Performance Units, Performance Shares or Cash-Based Awards earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding
                  performance goals and/or other terms and conditions have been achieved or satisfied.&#160; The Committee shall determine the extent to which any such pre-established performance goals and/or other terms and conditions of a Performance Unit,
                  Performance Share or Cash-Based Award are attained or not attained following conclusion of the applicable Performance Period.&#160; The Committee may, in its discretion, waive any such performance goals and/or other terms and conditions
                  relating to any such Award.&#160; The performance goals applicable to a payment hereunder may provide for a targeted level or levels of achievement using measures the Committee determines to be appropriate, including the following measures:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    </div>
    <div>
      <div style="float: left; width: 48%;" id="EFPFTCL">
        <div>
          <table cellspacing="0" cellpadding="0" id="zd4cee97e9bdc4a979d1bb42adda65a37" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">total shareholder return</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zf05c91bc3bef414aa8baa64bf1e83f75" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">revenue, earnings before interest and taxes, contribution margin, free cash flow or other financial measures of the Company, a subsidiary or a product line</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zacb2ed3b29cf481dacefcf77067a9223" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">return on equity, return on invested capital and similar metrics</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z8769171a3aaf4103994a63ba807d7345" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">launching a new investment product</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zc9db09945c264a61ac6a444f29b01aeb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">strategic partnerships or transactions</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z330a44bada0c403a85cf014b3d924f55" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">financial ratios, including those measuring liquidity, activity, profitability or leverage</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zbcc17c91585241f48214b20f73e112d4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">financing and other capital raising transactions (including sales of the Company&#8217;s equity or debt securities; factoring transactions)</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zc05ce238813c4dd5b9a7948590052c42" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">key performance indicators of middle office, back office and staff functions</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="za426d4430857412cb9dae30ce05d7afd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">co-development, co-marketing, profit sharing, joint venture or other similar arrangements</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z9bc79d41ee484363b7be3dbe39ec1b6e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">regulatory achievements (including submitting or filing applications or other documents with regulatory authorities or receiving approval of any such applications
                    or other documents; passing pre-approval inspections (whether of the Company, its affiliates or third parties))</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z07c7647cbfe34dd0ad7459cc73935cae" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">debt reduction</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="float: right; width: 48%;" id="EFPFTCR">
        <div>
          <table cellspacing="0" cellpadding="0" id="zefac486516a3491f91fc03c1bd1372f9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">appreciation in and/or maintenance of the price of the Shares or any other publicly-traded securities of the Company</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z1533bc6187c24ba6b75c00930c7eaa91" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">carried interest, general partner&#8217;s revenue, incentive fees or management fees from a particular investment product</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z91d81cca682d4109afe40860f418152c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">performance of attributed investments</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z51493ef0524a4e57a8aecd6696e9d300" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">obtaining investment commitments from investors, expanding and maintaining relationships with investors, sourcing new investors and other distribution activities</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z3f1c4b08ad4d4aab91505f94bf5f6343" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">operating efficiencies</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z5a3e9e009e294c2f826d1f636d33fe48" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">cost of capital or assets under management</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zd30bc53afdcc4fb6b471527be4349a8d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">revenue growth or product revenue growth</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="zc766ee885b2c4799bc30914ae7d1a8f1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">expense levels</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z9742ffcb83ea479c98547878a802bb89" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">economic value-added models or equivalent metrics</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z95d575f902464795b03d66a29b3d89c2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">cash flow or cash flow per share (before or after dividends) working capital levels, including cash, inventory and accounts receivable</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z1fa53ce3599a4cbf8e34fefaa143c5b5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">comparisons with various stock market indices</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="clear: both;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zeb651cd0b1904093bb65f135060efbf6">

            <tr>
              <td style="width: 100.00%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 15 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Such performance goals also may be based solely by reference to the Company&#8217;s performance or the performance of a Subsidiary, division, business
        segment or business unit of the Company, or based upon the relative performance of other companies or upon comparisons of any of the indicators of performance relative to other companies.&#160; The Committee may also exclude charges related to an event
        or occurrence which the Committee determines should appropriately be excluded, including (a) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (b) an event either not directly related to the
        operations of the Company or not within the reasonable control of the Company&#8217;s management, or (c) the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). The measures which
        constitute the performance goals may, at the discretion of the Committee, be based on pro forma numbers and may, as the Committee specifies, either include or exclude the effect of payment of the bonuses under the Plan or any other bonus plans of
        the Company.&#160; The performance goals may differ from Participant to Participant.&#160; Such performance goals shall be set by the Committee within the time period prescribed by, and shall otherwise comply with the requirements of, Code Section 162(m),
        and the regulations thereunder, to the extent applicable.&#160; In establishing a performance goal, the Committee may, to the extent doing so does not cause any amount payable hereunder that is intended to be performance-based compensation under Code
        Section 162(m) to cease to so qualify, provide that the attainment of the performance goal shall be measured by appropriately adjusting the evaluation of the performance goal performance to exclude (i) any extraordinary non-recurring items as
        defined under GAAP and/or in management&#8217;s discussion and analysis of financial condition and results of operations appearing in the Company&#8217;s annual report to stockholders for the applicable year, or (ii) the effect of any changes in accounting
        principles affecting the Company&#8217;s or a business unit&#8217;s reported results.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 16 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ef6ee71fc5e40309b75612d2e8ef980">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Form and Timing of Payment of Performance Units, Performance Shares and Cash-Based
                  Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Payment of earned Performance Units, Performance Shares and Cash-Based Awards shall be as determined by the Committee and as set forth in the Award Agreement.&#160;
                  Subject to the terms of the Plan, the Committee, in its sole discretion, may pay earned Performance Units, Performance Shares and Cash-Based Awards in the form of cash or in Shares (or in a combination thereof) which have an aggregate
                  Fair Market Value equal to the value of the earned Performance Units, Performance Shares or Cash-Based Awards as soon as practicable after the end of the Performance Period and following the Committee&#8217;s determination of actual performance
                  against the performance goals and/or other terms and conditions established by the Committee.&#160; Such Shares may be granted subject to any restrictions imposed by the Committee, including pursuant to Section 19.10.&#160; The determination of the
                  Committee with respect to the form of payment of such Awards shall be set forth in the Award Agreement pertaining to the grant of the Award.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3897d61c4fa94773bdc37f99e3eb6fec">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Rights as a Stockholder.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; A Participant receiving a Performance Unit, Performance Share or Cash-Based Award shall have the rights of a stockholder only as to Shares, if any, actually received by the Participant upon satisfaction or achievement
                  of the terms and conditions of such Award and not with respect to Shares subject to the Award but not actually issued to such Participant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9b2706cf84f403bacc42a3cc3341999">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Termination of Employment or Service.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Award Agreement shall set forth the extent to which the Participant shall have the right to retain Performance Units, Performance Shares and/or Cash-Based Award following such Participant&#8217;s Termination.&#160;
                  Such provisions shall be determined in the sole discretion of the Committee, shall be included in the applicable Award Agreement, need not be uniform among all such Awards issued pursuant to the Plan, and may reflect distinctions based on
                  the reasons for Termination.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6a9914caf0a4ba2aba11c72d958d514">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Additional Limitations</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.&#160; Notwithstanding any other provision of the Plan, any Award which is intended to constitute qualified performance-based compensation shall be subject to any additional limitations set forth in Code Section 162(m) or any
                  regulations or rulings issued thereunder that are requirements for qualification as qualified performance-based compensation as described in Code Section 162(m) and the Plan and the applicable Award Agreement shall be deemed amended to
                  the extent necessary to conform to such requirements.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0702a4995d5f4c9eacfd64527b235114">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">OTHER STOCK-BASED AWARDS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbd9ee6b710c84d05991d9f60e9648076">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Other Stock-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee may grant types of equity-based or equity-related Awards not otherwise described by the terms of the Plan (including the grant or offer for sale of unrestricted Shares), in such amounts (subject to
                  Article 3) and subject to such terms and conditions, as the Committee shall determine.&#160; Such Other Stock-Based Awards may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value
                  of Shares and may include Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 17 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z98351cd3d13c4f008dcdc04a87eebcd7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Value of Other Stock-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Other Stock-Based Award shall be expressed in terms of Shares or units based on Shares, as determined by the Committee.&#160; The Committee may establish performance goals in its discretion, and any such
                  performance goals shall be set forth in the applicable Award Agreement.&#160; If the Committee exercises its discretion to establish performance goals, the number and/or value of Other Stock-Based Awards that will be paid out to the
                  Participant will depend on the extent to which such performance goals are met.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb8bf5943669d4f18a861b6e548941921">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Payment of Other Stock-Based Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Payment, if any, with respect to an Other Stock-Based Award shall be made in accordance with the terms of the Award, as set forth in the Award Agreement, in cash or Shares as the Committee determines.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdcdcf2b8ba1842998bb2f6ee33ad2b5b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Termination of Employment or Service.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee shall determine the extent to which the Participant shall have the right to receive Other Stock-Based Awards following the Participant&#8217;s Termination.&#160; Such provisions shall be determined in the
                  sole discretion of the Committee, such provisions may be included in the applicable Award Agreement, but need not be uniform among all Other Stock-Based Awards issued pursuant to the Plan, and may reflect distinctions based on the reasons
                  for Termination.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z93b9f84ea623436a86875ca1afa2a58d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">DIVIDEND EQUIVALENTS</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Unless otherwise provided by the Committee, no adjustment shall be made in the Shares issuable or taken into account under Awards on account of cash dividends that may be paid or other rights that may be issued to the holders of
                  Shares prior to issuance of such Shares under such Award.&#160; The Committee may grant Dividend Equivalents based on the dividends declared on Shares that are subject to any Award, including any Award the payment or settlement of which is
                  deferred pursuant to Section 18.6.&#160; Dividend Equivalents may be credited as of the dividend payment dates, during the period between the date the Award is granted and the date the Award becomes payable or terminates or expires.&#160; Dividend
                  Equivalents may be subject to any limitations and/or restrictions determined by the Committee.&#160; Dividend Equivalents granted with respect to Performance Units and/or Performance Shares shall only be paid when and to the extent such
                  Award(s) are otherwise earned in accordance with their terms.&#160; Dividend Equivalents shall be converted to cash or additional Shares by such formula and at such time, and shall be paid at such times, as may be determined by the Committee.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6f54ba7f797432693d0beeec9cfd5a3">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">TRANSFERABILITY OF AWARD; BENEFICIARY DESIGNATION</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeccf7e8c74a24ef08da7e75f4bd43553">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Transferability of Incentive Stock Options.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; No ISO or Tandem SAR granted in connection with an ISO may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution or
                  in accordance with Section 11.3.&#160; Further, all ISOs and Tandem SARs granted in connection with ISOs granted to a Participant shall be exercisable during his or her lifetime only by such Participant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 18 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11b8711e5bf34d06b9a4e31e12af4d16">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">All Other Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except as otherwise provided in Section 7.5 or Section 11.3 or a Participant&#8217;s Award Agreement or otherwise determined at any time by the Committee, no Award granted under the Plan may be sold, transferred, pledged, assigned, or
                  otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution; provided that the Committee may permit further transferability, on a general or a specific basis, and may impose conditions and
                  limitations on any permitted transferability, subject to Section 11.1 and any applicable Period of Restriction; <font style="font-style: italic;">provided further</font>, however, that no Award may be transferred for value or other
                  consideration without first obtaining approval thereof by the stockholders of the Company.&#160; Further, except as otherwise provided in a Participant&#8217;s Award Agreement or otherwise determined at any time by the Committee, or unless the
                  Committee decides to permit further transferability, subject to Section 11.1 and any applicable Period of Restriction, all Awards granted to a Participant under the Plan, and all rights with respect to such Awards, shall be exercisable or
                  available during his or her lifetime only by or to such Participant.&#160; With respect to those Awards, if any, that are permitted to be transferred to another individual, references in the Plan to exercise or payment related to such Awards
                  by or to the Participant shall be deemed to include, as determined by the Committee, the Participant&#8217;s permitted transferee.&#160; If any Award is exercised by or otherwise paid to the executors, administrators, heirs or distributees of the
                  estate of a deceased Participant, or such a Participant&#8217;s beneficiary, or the transferee of an Award, in any such case, pursuant to the terms and conditions of the Plan and the applicable Agreement and in accordance with such terms and
                  conditions as may be specified from time to time by the Committee, the Company shall be under no obligation to issue Shares thereunder unless and until the Company is satisfied, as determined in the discretion of the Committee, that the
                  person or persons exercising such Award, or to receive such payment, are the duly appointed legal representative of the deceased Participant&#8217;s estate or the proper legatees or distributees thereof or the named beneficiary of such
                  Participant, or the valid transferee of such Award, as applicable.&#160; Any purported assignment, transfer or encumbrance of an Award that does not comply with this Section 11.2 shall be void and unenforceable against the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ea12c56a88248359a5c9548897329c5">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Beneficiary Designation.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Each Participant may, from time to time, name any beneficiary or beneficiaries who shall be permitted to exercise his or her Option or SAR or to whom any benefit under the Plan is to be paid in case of the
                  Participant&#8217;s death before he or she fully exercises his or her Option or SAR or receives any or all of such benefit.&#160; Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the
                  Company, and will be effective only when filed by the Participant in writing with the Company during the Participant&#8217;s lifetime.&#160; In the absence of any such beneficiary designation, a Participant&#8217;s unexercised Option or SAR, or amounts
                  due but remaining unpaid to such Participant, at the Participant&#8217;s death, shall be exercised or paid as designated by the Participant by will or by the laws of descent and distribution.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3a37ead66c744caf9f253ce2ef77cf11">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">RIGHTS OF PARTICIPANTS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 19 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdef6fdfc8b984a8f889f27d1b72fdf83">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Rights or Claims.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; No person shall have any rights or claims under the Plan except in accordance with the provisions of the Plan and any applicable Award Agreement.&#160; Unless the Committee determines otherwise, a Participant shall not have any rights
                  as a shareholder with respect to shares of stock covered by an Award until the date the Participant becomes the holder of record with respect to such shares.&#160; The liability of the Company and any Subsidiary or Affiliate under the Plan is
                  limited to the obligations expressly set forth in the Plan, and no term or provision of the Plan may be construed to impose any further or additional duties, obligations, or costs on the Company, any Subsidiary or any Affiliate thereof or
                  the Board or the Committee not expressly set forth in the Plan.&#160; The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are
                  specified in the Plan as being applicable to such type of Award, or to all Awards, or as are expressly set forth in the Award Agreement evidencing such Award.&#160; Without limiting the generality of the foregoing, neither the existence of the
                  Plan nor anything contained in the Plan or in any Award Agreement shall be deemed to:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6343c409a2a14f25b74671a513358c15">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Give any Employee or Non-Employee Director the right to be retained in the service of the Company, an Affiliate and/or a Subsidiary, whether in any particular position, at any particular rate of compensation, for any particular period of
                time or otherwise;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc793ea18dd6a495ca072f0cb02160fa9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Restrict in any way the right of the Company, an Affiliate and/or a Subsidiary to terminate, change or modify any Employee&#8217;s employment or any Non-Employee Director&#8217;s service as a Director at any time with or without Cause;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd25b68bdcf1844dfbe2e7b78b9e9b293">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Confer on any Consultant any right of continued relationship with the Company, an Affiliate and/or a Subsidiary, or alter any relationship between them, including any right of the Company or an Affiliate or Subsidiary to terminate,
                change or modify its relationship with a Consultant;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb81a5fcd23e74a99b588e41f4ffbb852">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Constitute a contract of employment or service between the Company or any Affiliate or Subsidiary and any Employee, Non-Employee Director or Consultant, nor shall it constitute a right to remain in the employ or service of the Company or
                any Affiliate or Subsidiary;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc8728f7f0637459986173ee7c80584b9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Give any Employee, Non-Employee Director or Consultant the right to receive any bonus, whether payable in cash or in Shares, or in any combination thereof, from the Company, an Affiliate and/or a Subsidiary, nor be construed as limiting
                in any way the right of the Company, an Affiliate and/or a Subsidiary to determine, in its sole discretion, whether or not it shall pay any Employee, Non-Employee Director or Consultant bonuses, and, if so paid, the amount thereof and the
                manner of such payment; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf714404ffbb847e6bc743b85139cbaf9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Give any Participant any rights whatsoever with respect to an Award except as specifically provided in the Plan and the Award Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c52110325a04ea88177ebc0acdc8cf6">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Effects on Benefits.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Payments and other compensation received by a Participant under an Award are not part of such Participant&#8217;s normal or expected compensation or salary for any purpose, including calculating termination, indemnity,
                  severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments under any laws, plans, contracts, policies, programs, arrangements or otherwise.&#160; No claim or
                  entitlement to compensation or damages arises from the termination of the Plan or diminution in value of any Award or Shares purchased or otherwise received under the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 20 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3e42f50965254f7fa632a7e1acaad986">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">CHANGE OF CONTROL</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33eed8cef4484a4b8dbe98780ed9af74">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Treatment of Outstanding Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; In the event of a Change of Control, unless otherwise specifically prohibited by any applicable laws, rules or regulations or otherwise provided in any applicable Award Agreement, as in effect prior to the occurrence
                  of the Change of Control, specifically with respect to a Change of Control:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0467b338e3e94fcda62944d344f7f78e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>In its discretion, and on such terms and conditions as it deems appropriate, the Committee may provide, either by the terms of the Award Agreement or by resolution adopted prior to the occurrence of such Change of Control, that any
                Awards which are outstanding shall, as applicable and in whole or in part, become vested, non-forfeitable and/or exercisable; have the restrictions, performance goals, Period of Restriction or other conditions applicable to such Awards be
                canceled, terminated or deemed achieved or have any restrictions on transfer, sale assignment, pledge or other disposition (including with respect to Shares issuable under such Award) lapse and/or that any Award the payment or settlement of
                which was deferred under Section 18.6 or otherwise may be paid or distributed immediately prior to the Change of Control, subject to Section 15.6.&#160; Without limiting the foregoing, in its discretion, and on such terms and conditions as it
                deems appropriate, the Committee may provide, either by the terms of the Award Agreement or by resolution adopted prior to the occurrence of such Change of Control, that the target payment opportunities attainable under any outstanding
                Awards of Performance Units, Performance Shares, Cash-Based Awards and other Awards shall be deemed to have been fully or partially earned for any Performance Period(s), immediately prior to the effective date of the Change of Control.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7780381c339242cda4bbdf2da41c1936">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>In its discretion and in accordance with the terms of the Plan, provide that all or certain Awards be Assumed or Replaced.&#160; In the event that an Award is not Assumed or Replaced, or in the event of a liquidation of the Company, then such
                Award shall, as applicable, become fully vested, non-forfeitable and/or exercisable; have the restrictions, performance goals, Period of Restriction or other conditions applicable to such Award canceled, terminated or deemed achieved or
                have any restrictions on transfer, sale assignment, pledge or other disposition (including with respect to Shares issuable under such Award) lapse immediately prior to the Change of Control and the target payment opportunities under such
                outstanding Award of Performance Units, Performance Shares, Cash-Based Awards or other Award shall be deemed to have been fully earned for the entire Performance Period(s) immediately prior to the Change of Control.&#160; Further, unless
                otherwise provided in any applicable Award Agreement, as in effect prior to the occurrence of the Change of Control, if a Participant with respect to whom an Award has been Assumed or Replaced incurs a Termination, either by the Company, an
                Affiliate or a Subsidiary without Cause or by the Participant for Good Reason (a &#8220;Terminated Participant&#8221;), after the Change of Control, then subject to Section 13(b)(b)(i) all outstanding Awards that are held by such Terminated
                Participant, as the case may be, shall become fully vested, non-forfeitable and/or exercisable; have the restrictions, performance goals, Period of Restriction or other conditions applicable to such Award canceled, terminated or deemed
                achieved or have any restrictions on transfer, sale assignment, pledge or other disposition (including with respect to Shares issuable under such Award) lapse immediately prior to the Change of Control.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 21 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160; Notwithstanding Section 13.1(b), with respect to outstanding Awards of Performance Units, Performance Shares, Cash-Based Awards or other
        Awards, the target payment opportunities under such outstanding Awards of Performance Units, Performance Shares, Cash-Based Awards or other Award shall be deemed to have been fully earned for the entire Performance Period(s) immediately prior to
        the Change of Control, in each case immediately preceding, or upon the occurrence of the failure to assume or replace such Awards or upon a Termination described in Section 14.1(b) and (A) there shall be paid out to each Participant holding such an
        Award denominated in Shares, not later than five days prior to the effective date of the Change of Control, in the case of such Awards that are not Assumed or Replaced, or upon the occurrence of such Termination, in the case of a Termination
        described in Section 13.1(b), a pro rata number of Shares (or the equivalent Fair Market Value thereof, as determined by the Committee, in cash) based upon an assumed achievement of all relevant targeted performance goals, unless actual performance
        exceeds the target, in which case actual performance shall be used, and upon the length of time within the Performance Period which has elapsed prior to the Change of Control or such Termination, as the case may be, and (B) Awards denominated in
        cash shall be paid pro rata to the applicable Participant or Participants in cash within thirty days following the effective date of the Change of Control, in the case of such Awards that are not Assumed or Replaced, or within thirty days following
        the occurrence of such Termination, in the case of a Termination described in Section 13.1(b), with the pro-ration determined as a function of the length of time within the Performance Period which has elapsed prior to the Change of Control or
        Termination, as the case may be, and based on an assumed achievement of all relevant targeted performance goals, unless actual performance exceeds the target, in which case actual performance shall be used.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z096cce3b5b144fa5b2b01ea442764c48">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>In its discretion, and on such terms and conditions as it deems appropriate, the Committee may provide, either by the terms of the Award Agreement applicable to any Award or by resolution adopted prior to the occurrence of the Change of
                Control, that any outstanding Award shall be adjusted by substituting for each Share subject to such Award immediately prior to the transaction resulting in the Change of Control the consideration (whether stock or other securities of the
                surviving corporation or any successor corporation to the Company, or a parent or subsidiary thereof, or that may be issuable by another corporation that is a party to the transaction resulting in the Change of Control) received in such
                transaction by holders of Shares for each Share held on the closing or effective date of such transaction, in which event the aggregate Option Price or Grant Price, as applicable, of the Award shall remain the same; <font style="font-style: italic;">provided,</font> however, that if such consideration received in such transaction is not solely stock of a successor, surviving or other corporation, the Committee may provide for the consideration to be
                received upon exercise or payment of an Award, for each Share subject to such Award, to be solely stock or other securities of the successor, surviving or other corporation, as applicable, equal in fair market value, as determined by the
                Committee, to the per-Share consideration received by holders of Shares in such transaction.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 22 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc18c25e517e84ecd810ed6d459487850">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>In its discretion, and on such terms and conditions as it deems appropriate, the Committee may provide, either by the terms of the Award Agreement applicable to any Award or by resolution adopted prior to the occurrence of the Change of
                Control, that any outstanding Award (or portion thereof) shall be converted into a right to receive cash, on or as soon as practicable following the closing date or expiration date of the transaction resulting in the Change of Control in an
                amount equal to the highest value of the consideration to be received in connection with such transaction for one Share, or, if higher, the highest Fair Market Value of a Share during the thirty consecutive business days immediately prior
                to the closing date or expiration date of such transaction, less the per-Share Option Price, Grant Price or outstanding unpaid purchase price, as applicable to the Award, multiplied by the number of Shares subject to such Award, or the
                applicable portion thereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd00e5d83a1e24bc0b2f0454bee491d49">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Committee may, in its discretion, provide that an Award can or cannot be exercised after, or will otherwise terminate or not terminate as of, a Change of Control.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b5841b586c941b4b8ed0a6d5a428d54">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Implied Rights; Other Limitations.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; No Participant shall have any right to prevent the consummation of any of the acts described in Section 3.2 or 13.1 affecting the number of Shares available to, or other entitlement of, such Participant under
                  the Plan or such Participant&#8217;s Award.&#160; Any actions or determinations of the Committee under this Article XIV need not be uniform as to all outstanding Awards, nor treat all Participants identically.&#160; Notwithstanding the adjustments
                  described in Section 13.1, in no event may any Option or SAR be exercised after ten years from the date it was originally granted, and any changes to ISOs pursuant to this Article 13 shall, unless the Committee determines otherwise, only
                  be effective to the extent such adjustments or changes do not cause a &#8220;modification&#8221; (within the meaning of Code Section 424(h)(3)) of such ISOs or adversely affect the tax status of such ISOs.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24c1f6bd92b24575a26c65a0951baab1">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">AMENDMENT, MODIFICATION AND TERMINATION</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z816bd33b84174352b004aad2962e52ef">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Amendment, Modification, and Termination.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Board may, at any time and with or without prior notice, amend, alter, suspend, or terminate the Plan, and the Committee may, to the extent permitted by the Plan, amend the terms of any Award theretofore
                  granted, including any Award Agreement, in each case, retroactively or prospectively; <font style="font-style: italic;">provided</font>, however, that no such amendment, alteration, suspension, or termination of the Plan shall be made
                  which, without first obtaining approval of the stockholders of the Company (where such approval is necessary to satisfy (i) the then-applicable requirements of Rule 16b-3, (ii) any requirements under the Code relating to ISOs, or (iii)
                  any applicable law, regulation or rule (including the applicable regulations and rules of the SEC and any national securities exchange)), would:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zedec018dd9b34ef9a01970c7df23f01c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>except as is provided in Section 3.2, increase the maximum number of Shares which may be sold or awarded under the Plan;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf38ee705f57a41aa9c4b18fc1bb5c972">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>except as is provided in Section 3.2, decrease the minimum Option Price or Grant Price requirements of Sections 5.3 and 6.2, respectively;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd4817afc27c4bdfb8a2b420af450f16">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>change the class of persons eligible to receive Awards under the Plan;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40692adb0d3847eba55824dd1a781c34">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>extend the duration of the Plan or the period during which Options or SARs may be exercised under Section 5.4 or 6.6, as applicable; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 23 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2c79952db7b41d9a488d2a8a79b8bde">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>otherwise require stockholder approval to comply with any applicable law, regulation or rule (including the applicable regulations and rules of the SEC and any national securities exchange).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z55372b0bf2d34e0781ec1667b8d8bf47" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In addition, (i) no such amendment, alteration, suspension or termination of the Plan or any Award theretofore granted, including any Award Agreement, shall
                  be made which would materially impair the previously accrued rights of a Participant under any outstanding Award without the written consent of such Participant, <font style="font-style: italic;">provided</font>, however, that the Board
                  may amend or alter the Plan and the Committee may amend or alter any Award, including any Agreement, either retroactively or prospectively, without the consent of the applicable Participant, (A) so as to preserve or come within any
                  exemptions from liability under Section 16(b) of the Exchange Act, pursuant to the rules and releases promulgated by the SEC (including Rule 16b-3), (B) if the Board or the Committee determines in its discretion that such amendment or
                  alteration either (1) is required or advisable for the Company, the Plan or the Award to satisfy, comply with or meet the requirements of any law, regulation, rule or accounting standard or (2) is not reasonably likely to significantly
                  diminish the benefits provided under such Award, or that such diminishment has been or will be adequately compensated, or (C) with respect to any Award that is granted to a Participant and is intended to constitute qualified
                  performance-based compensation under Code Section 162(m), if the Board or the Committee determines in its discretion that such amendment or alteration is necessary under Section 162(m) (including any amendment to Section 162(m)) or any
                  regulations and ruling issued thereunder to ensure that the Awards satisfy the requirements for qualification under Code Section 162(m) and (ii) except as is provided in Section 3.2, but notwithstanding any other provisions of the Plan,
                  neither the Board nor the Committee may take any action: (A) to amend the terms of an outstanding Option or SAR to reduce the Option Price or Grant Price thereof, cancel an Option or SAR and replace it with a new Option or SAR with a
                  lower Option Price or Grant Price, or that has an economic effect that is the same as any such reduction or cancellation; or (B) to cancel an outstanding Option or SAR having an Option Price or Grant Price above the then-current Fair
                  Market Value of the Shares in exchange for cash or for the grant of another type of Award, without, in each such case, first obtaining approval of the stockholders of the Company of such action.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ca456fb8ba748b49d68b481a9e49b40">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Board or the Committee shall make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or non-recurring events (including
                  the events described in Section 3.2) affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Board or the Committee determines that such
                  adjustments are necessary to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdd7e79b796fb42ce89b65c8a256f9acf" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Any such adjustment with respect to an Award intended to be an ISO shall be made only to the extent consistent with such intent, unless the Board or the
                  Committee determines otherwise.&#160; The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under the Plan.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 24 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02dc2b70ce09428091762ec768b85675">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">TAX WITHHOLDING AND OTHER TAX MATTERS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f2a900b26fa41858fdf548f4f59d5fd">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Tax Withholding.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Company and/or any Subsidiary or Affiliate are authorized to withhold from any Award granted or payment due under the Plan the amount of all Federal, state, local and non-United States taxes due in respect of such Award or
                  payment and take any such other action as may be necessary or appropriate, as determined by the Committee, to satisfy all obligations for the payment of such taxes.&#160; The recipient of any payment or distribution under the Plan shall make
                  arrangements satisfactory to the Company, as determined in the Committee&#8217;s discretion, for the satisfaction of any tax obligations that arise by reason of any such payment or distribution.&#160; The Company shall not be required to make any
                  payment or distribution under or relating to the Plan or any Award until such obligations are satisfied or such arrangements are made, as determined by the Committee in its discretion.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z431ef8d12ea64f048f491742e46da101">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Withholding or Tendering Shares.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Without limiting the generality of Section 16.1, the Committee may in its discretion permit a Participant to satisfy or arrange to satisfy, in whole or in part, the tax obligations incident to an Award by: (a) electing
                  to have the Company withhold Shares or other property otherwise deliverable to such Participant pursuant to his or her Award (<font style="font-style: italic;">provided</font>, however, that the amount of any Shares so withheld shall not
                  exceed the amount necessary to satisfy required Federal, state, local and non-United States withholding obligations using the maximum statutory withholding rates for Federal, state, local and/or non-U.S.&#160; tax purposes, including payroll
                  taxes, that are applicable to supplemental taxable income) and/or (b) tendering to the Company Shares owned by such Participant (or by such Participant and his or her spouse jointly) and purchased or held for the requisite period of time
                  as may be required to avoid the Company&#8217;s or the Affiliates&#8217; or Subsidiaries&#8217; incurring an adverse accounting charge, based, in each case, on the Fair Market Value of the Shares on the payment date as determined by the Committee.&#160; All
                  such elections shall be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1fadaf09a4824969b6ce13b538aea64b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Special ISO Obligations.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The Committee may require a Participant to give prompt written notice to the Company concerning any disposition of Shares received upon the exercise of an ISO within: (a) two years from the date of granting such ISO to
                  such Participant or (b) one year from the transfer of such Shares to such Participant or (c) such other period as the Committee may from time to time determine.&#160; The Committee may direct that a Participant with respect to an ISO undertake
                  in the applicable Award Agreement to give such written notice described in the preceding sentence, at such time and containing such information as the Committee may prescribe, and/or that the certificates evidencing Shares acquired by
                  exercise of an ISO refer to such requirement to give such notice.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zebed5962334840438753dc6c7e09c298">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 83(b) Election.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; If a Participant makes an election under Code Section 83(b) to be taxed with respect to an Award as of the date of transfer of Shares rather than as of the date or dates upon which the Participant would otherwise be
                  taxable under Code Section 83(a), such Participant shall deliver a copy of such election to the Company immediately after filing such election with the Internal Revenue Service.&#160; Neither the Company nor any Subsidiary or Affiliate shall
                  have any liability or responsibility relating to or arising out of the filing or not filing of any such election or any defects in its construction.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 25 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z921fc05b9c204fecb38c14dbbea76a1d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Guarantee of Favorable Tax Treatment.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Although the Company intends to administer the Plan so that Awards will be exempt from, or will comply with, the requirements of Code Section 409A, the Company does not warrant that any Award under the Plan
                  will qualify for favorable tax treatment under Code Section 409A or any other provision of federal, state, local, or non-United States law.&#160; The Company shall not be liable to any Participant for any tax, interest, or penalties the
                  Participant might owe as a result of the grant, holding, vesting, exercise, or payment of any Award under the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdcf15cd958a94c6db664a2174933b4f8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Non-Qualified Deferred Compensation.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8dbaa902e46e454e9161ce3722672641">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>If any Award would be considered deferred compensation as defined under Code Section 409A and would fail to meet the requirements of Code Section 409A, then such Award shall be null and void; provided, however, that the Committee may
                permit deferrals of compensation pursuant to the terms of a Participant&#8217;s Award Agreement, a separate plan, or a subplan which (in each case) meets the requirements of Code Section 409A.&#160; Additionally, to the extent any Award is subject to
                Code Section 409A, notwithstanding any provision herein to the contrary, the Plan shall not permit the acceleration of the time or schedule of any distribution related to such Award, except as permitted by Code Section 409A.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a85cc03e2734679b1f25b367e8f26ab">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Notwithstanding any provisions of the Plan to the contrary, in no event shall any deferral under Section 18.6 be permitted if the Committee determines that such deferral would result in the imposition of additional tax under Code Section
                409A.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ad21bf1ec5e406ab7a20ac9f9740fb6">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Committee shall not extend the period to exercise an Option or Stock Appreciation Right to the extent that such extension would cause the Option or Stock Appreciation Right to become subject to Code Section 409A.&#160; An Award Agreement
                may provide that the period of time over which an NQSO may be exercised shall be automatically extended if on the scheduled expiration date of such Option the Participant&#8217;s exercise of such Option would violate applicable securities laws; <font style="font-style: italic;">provided</font>, however, that during such extended exercise period the Option may only be exercised to the extent the Option was exercisable in accordance with its terms immediately prior to such scheduled
                expiration date; <font style="font-style: italic;">provided</font> <font style="font-style: italic;">further</font>, however, that such extended exercise period shall end not later than thirty days after the exercise of such Option first
                would no longer violate such laws.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd60ff47d57f84cab84c8c47e8bdec7d5">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Unless the Committee provides otherwise in an Award Agreement, each Restricted Stock Unit, Performance Unit, Performance Share, Cash-Based Award and/or Other Stock-Based Award shall be paid in full to the Participant no later than the
                fifteenth day of the third month after the end of the first calendar year in which such Award is no longer subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Code Section 409A.&#160; If the Committee provides in an Award
                Agreement that a Restricted Stock Unit, Performance Unit, Performance Share, Cash-Based Award or Other Stock-Based Award is intended to be subject to Code Section 409A, the Award Agreement shall include terms that are intended to satisfy
                the requirements of Code Section 409A.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 26 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4b3884b909c549279fb78b564d8248af">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>No Dividend Equivalents shall relate to Shares underlying an Option or SAR unless such Dividend Equivalent rights are explicitly set forth as a separate arrangement and do not cause any such Option or SAR to be subject to Code Section
                409A.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2b343ec89b8647568e2ecd8ba871d1a8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Notwithstanding any other provisions of the Plan or any Award Agreement to the contrary, if a Termination that is not a Separation from Service occurs, and payment or distribution of an Award constituting deferred compensation subject to
                Code Section 409A would otherwise be made or commence on the date of such Termination (pursuant to the Plan, the Award Agreement or otherwise), (i) the vesting of such Award shall accelerate in accordance with the Plan and the Award
                Agreement, (ii) such payment or distribution shall not be made or commence prior to the earliest date on which Code Section 409A permits such payment or distribution to be made or commence without additional taxes or penalties under Code
                Section 409A, and (iii) in the event any such payment or distribution is deferred in accordance with the immediately preceding clause (ii), such payment or distribution that would have been made prior to the deferred payment or commencement
                date, but for Code Section 409A, shall be paid or distributed on such earliest payment or commencement date, together, if determined by the Committee, with interest at the rate established by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z401ec32d3e31419481a4b53229759532">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Notwithstanding any other provisions of the Plan or any Award Agreement to the contrary, if a Change of Control that is not a Qualified Change of Control occurs, and payment or distribution of an Award constituting deferred compensation
                subject to Code Section 409A would otherwise be made or commence on the date of such Change of Control (pursuant to the Plan, the Award Agreement or otherwise), (i) the vesting of such Award shall accelerate in accordance with the Plan and
                the Award Agreement, (ii) such payment or distribution shall not be made or commence prior to the earliest date on which Code Section 409A permits such payment or distribution to be made or commence without additional taxes or penalties
                under Code Section 409A, and (iii) in the event any such payment or distribution is deferred in accordance with the immediately preceding clause (ii), such payment or distribution that would have been made prior to the deferred payment or
                commencement date, but for Code Section 409A, shall be paid or distributed on such earliest payment or commencement date, together, if determined by the Committee, with interest at the rate established by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4abe5f73d22446088b82b2e1f84e1741">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Although the Company intends to administer the Plan so that Awards will be exempt from, or will comply with, the requirements of Code Section 409A, the Company does not warrant that any Award under the Plan will qualify for favorable tax
                treatment under Code Section 409A or any other provision of federal, state, local, or non-United States law.&#160; The Company shall not be liable to any Participant for any tax, interest, or penalties the Participant might owe as a result of
                the grant, holding, vesting, exercise, or payment of any Award under the Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 27 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb8100c5c1cea4f039a82ba01cc71ebf3">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">LIMITS OF LIABILITY; INDEMNIFICATION</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8e8731df88a4884920edc42c0ae2056">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Limits of Liability</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb1a6554c258446318923cee9d1c6c142">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Any liability of the Company or a Subsidiary or Affiliate to any Participant with respect to any Award shall be based solely upon contractual obligations created by the Plan and the Award Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc23161ed817a49c2b95ffe5f924ffb2c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>None of the Company, any Subsidiary, any Affiliate, any member of the Board or the Committee or any other person participating in any determination of any question under the Plan, or in the interpretation, administration or application
                of the Plan, shall have any liability, in the absence of bad faith, to any party for any action taken or not taken in connection with the Plan, except as may expressly be provided by statute.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3192f9c3bafd4e6a89a7153fccf8506e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Each member of the Committee, while serving as such, shall be considered to be acting in his or her capacity as a director of the Company.&#160; Members of the Board of Directors and members of the Committee acting under the Plan shall be
                fully protected in relying in good faith upon the advice of counsel and shall incur no liability except for gross negligence or willful misconduct in the performance of their duties.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z16b9592bc90442118d9e99b83a4bb14a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Committee may, with the approval of the Board, employ such attorneys and/or consultants, accountants, appraisers, brokers, agents and other persons, any of whom may be an Employee, as the Committee deems necessary or appropriate.&#160;
                The Committee, the Company and its officers and Directors shall be entitled to rely upon the advice, opinions or valuations of any such persons.&#160; The Committee shall not incur any liability for any action taken in good faith in reliance
                upon the advice of such counsel or other persons.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze3f6b8677b434fbbb7cf2480defe758e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Company shall not be liable to a Participant or any other person as to: (i) the non-issuance of Shares as to which the Company has been unable to obtain from any regulatory body having relevant jurisdiction the authority deemed by
                the Committee or the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, and (ii) any tax consequence expected, but not realized, by any Participant or other person due to the receipt, exercise or
                settlement of any Option or other Award.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z332bb3a81ed74a8eb71c97e6c2a97c71">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Indemnification.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Subject to the requirements of Delaware law, each individual who is or shall have been a member of the Committee or of the Board, or an officer of the Company to whom authority was delegated in accordance with Article 2, shall be
                  indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding
                  to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company&#8217;s
                  approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before
                  he or she undertakes to handle and defend it on his or her own behalf, unless such loss, cost, liability, or expense is a result of the individual&#8217;s own willful misconduct or except as provided by statute.&#160; The foregoing right of
                  indemnification shall not be exclusive of any other rights of indemnification to which such individual may be entitled under the Company&#8217;s certificate of incorporation or bylaws, as a matter of law, or otherwise, or any power that the
                  Company may have to indemnify or hold harmless such individual.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 28 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21e8737d98ab408cb016585655373a3e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">SUCCESSORS.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger,
                  consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99d5a8abe67d488aa912f8225f82587a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">MISCELLANEOUS</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zabf139a1daf240588d0e864d080f6dae">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Drafting Context; Captions.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the plural.&#160; The words &#8220;Article,&#8221;
                  &#8220;Section,&#8221; and &#8220;paragraph&#8221; herein shall refer to provisions of the Plan, unless expressly indicated otherwise.&#160; The words &#8220;include,&#8221; &#8220;includes,&#8221; and &#8220;including&#8221; herein shall be deemed to be followed by &#8220;without limitation&#8221; whether or not
                  they are in fact followed by such words or words of similar import, unless the context otherwise requires.&#160; The headings and captions appearing herein are inserted only as a matter of convenience.&#160; They do not define, limit, construe, or
                  describe the scope or intent of the provisions of the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a7d9e2460e34717a5282df98219ddf7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Forfeiture Events.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z013d68554d704fed8b3a720dd20e9269">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Notwithstanding any provision of the Plan to the contrary, the Committee shall have the authority to determine (and may so provide in any Agreement) that a Participant&#8217;s (including his or her estate&#8217;s, beneficiary&#8217;s or transferee&#8217;s)
                rights (including the right to exercise any Option or SAR), payments and benefits with respect to any Award shall be subject to reduction, cancellation, forfeiture or recoupment (to the extent permitted by applicable law) in the event of
                the Participant&#8217;s Termination for Cause or due to voluntary resignation; serious misconduct; violation of the Company&#8217;s or a Subsidiary&#8217;s or Affiliate&#8217;s policies; breach of fiduciary duty; unauthorized disclosure of any trade secret or
                confidential information of the Company or a Subsidiary or Affiliate; breach of applicable non-competition, non-solicitation, confidentiality or other restrictive covenants; or other conduct or activity that is in competition with the
                business of the Company or any Subsidiary or Affiliate, or otherwise detrimental to the business, reputation or interests of the Company and/or any Subsidiary or Affiliate; or upon the occurrence of certain events specified in the
                applicable Award Agreement (in any such case, whether or not the Participant is then an Employee, Non-Employee Director or Consultant).&#160; The determination of whether a Participant&#8217;s conduct, activities or circumstances are described in the
                immediately preceding sentence shall be made by the Committee in its good faith discretion, and pending any such determination, the Committee shall have the authority to suspend the exercise, payment, delivery or settlement of all or any
                portion of such Participant&#8217;s outstanding Awards pending an investigation of the matter.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 29 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b0a6223cd3e4a9ca63aebe45f705f54">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>If the Company is required to prepare an accounting restatement (i) due to the material non-compliance of the Company, as a result of misconduct, with any financial reporting requirement under the securities laws, if a Participant
                knowingly or grossly negligently engaged in such misconduct, or knowingly or grossly negligently failed to prevent such misconduct, or if a Participant is one of the individuals subject to automatic forfeiture under Section 304 of the
                Sarbanes-Oxley Act of 2002, the Participant shall reimburse the Company the amount of any payment in settlement of an Award earned or accrued during the twelve-month period following the first public issuance or filing with the SEC
                (whichever just occurred) of the financial document embodying such financial reporting requirement, and (ii) the Committee may in its discretion provide that if the amount earned under any Participant&#8217;s Award is reduced by such restatement,
                such Participant shall reimburse the Company the amount of any such reduction previously paid in settlement of such Award.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f45a4ee72bd468f82c10428801d09da">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Waiver.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; No
                  failure or delay in the exercise or assertion of any right of the Company hereunder will impair such right or be construed to be a waiver of, or acquiescence in, or create an estoppel with respect to any covenant herein, nor will any
                  single or partial exercise of any such right preclude other or further exercise thereof or of any other right.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce0370d40ddc453fba241ca1a1dd5329">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Severability.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Any term or provision hereof that is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable in any situation in any jurisdiction will not affect the validity or enforceability of the remaining
                  terms and provisions hereof or the validity or enforceability of the invalid, void or unenforceable term or provision in any other situation or in any other jurisdiction.&#160; If the final judgment of a court of competent jurisdiction or
                  other authority declares any term or provision hereof invalid, void or unenforceable, the court or other authority making such determination will have the power to and will, subject to the discretion of such body, reduce the scope,
                  duration, area or applicability of the term or provision, to delete specific words or phrases, or to replace any invalid, void or unenforceable term or provision with a term or provision that is valid and enforceable and that comes
                  closest to expressing the intention of the invalid or unenforceable term or provision.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf612d7449a4e4cbd80aa59942c0e1287">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Transfer, Leave of Absence.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; For purposes of the Plan, a transfer of an Employee from the Company to an Affiliate or Subsidiary (or, for purposes of any ISO granted under the Plan, only a Subsidiary), or vice versa, or from one Affiliate or
                  Subsidiary to another (or in the case of an ISO, only from one Subsidiary to another), and a leave of absence, duly authorized in writing by the Company or a Subsidiary or Affiliate, shall not be deemed a Termination of the Employee for
                  purposes of the Plan or with respect to any Award (in the case of ISOs, to the extent permitted by the Code).&#160; The Committee shall have the discretion to determine the effects upon any Award, upon an individual&#8217;s status as an Employee,
                  Non-Employee Director or Consultant for purposes of the Plan (including whether a Participant shall be deemed to have experienced a Termination or other change in status) and upon the exercisability, vesting, termination or expiration of
                  any Award in the case of: (a) any Participant who is employed by an entity that ceases to be an Affiliate or Subsidiary (whether due to a spin-off or otherwise), (b) any transfer of a Participant between locations of employment with the
                  Company, an Affiliate, and/or Subsidiary or between the Company, an Affiliate or Subsidiary or between Affiliates or Subsidiaries, (c) any leave of absence of a Participant, (d) any change in a Participant&#8217;s status from an Employee to a
                  Consultant or a Non-Employee Director, or vice versa; and (e) upon approval by the Committee, any Employee who experiences a Termination but becomes employed by a partnership, joint venture, corporation or other entity not meeting the
                  requirements of an Affiliate or Subsidiary, subject, in each case, to the requirements of Code Section 422 applicable to any ISOs and Code Section 409A applicable to any Options and SARs.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 30 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf2f714366fa4db383ce8f13d7dffd3c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise and Payment of Awards.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; An Award shall be deemed exercised or claimed when the Secretary of the Company or any other Company official or other person designated by the Committee for such purpose receives appropriate written notice from a
                  Participant, in form acceptable to the Committee, together with payment of the applicable Option Price, Grant Price or other purchase price, if any, and compliance with Article 13, in accordance with the Plan and such Participant&#8217;s Award
                  Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zefa1b2c2938f47dbabb240dd275dd223">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Deferrals.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; To
                  the extent provided in the Award Agreement, the Committee may permit or require a Participant to defer such Participant&#8217;s receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant by virtue
                  of the lapse or waiver of the Period of Restriction or other restrictions with respect to Restricted Stock or the payment or satisfaction of Restricted Stock Units, Performance Units, Performance Shares, Cash-Based Awards or Other
                  Stock-Based Awards.&#160; If any such deferral election is required or permitted, (a) such deferral shall represent an unfunded and unsecured obligation of the Company and shall not confer the rights of a stockholder unless and until Shares
                  are issued thereunder; (b) the number of Shares subject to such deferral shall, until settlement thereof, be subject to adjustment pursuant to Section 3.2; and (c) the Committee shall establish rules and procedures for such deferrals and
                  payment or settlement thereof, which may be in cash, Shares or any combination thereof, and such deferrals may be governed by the terms and conditions of any deferred compensation plan of the Company or Affiliate specified by the
                  Committee for such purpose.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2442a21465846158a94460a8b2aac48">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Loans.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; The
                  Company may, in the discretion of the Committee, extend one or more loans to Participants in connection with the exercise or receipt of an Award granted to any such Participant; provided, however, that the Company shall not extend loans
                  to any Participant if prohibited by law or the rules of any stock exchange or quotation system on which the Company&#8217;s securities are listed.&#160; The terms and conditions of any such loan shall be established by the Committee.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc53d4fb3a7c64a8daa7b7818468587f8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Effect on Other Plans.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Neither the adoption of the Plan nor anything contained herein shall affect any other compensation or incentive plans or arrangements of the Company or any Subsidiary or Affiliate, or prevent or limit the right of the
                  Company or any Subsidiary or Affiliate to establish any other forms of incentives or compensation for their directors, officers, eligible employees or consultants or grant or assume options or other rights otherwise than under the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 31 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zde65b7aec1bb4465a94c41e1ac6edd47">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.10</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 16 of Exchange Act.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Unless otherwise stated in the Award Agreement, notwithstanding any other provision of the Plan, any Award granted to an Insider shall be subject to any additional limitations set forth in any applicable exemptive rule
                  under Section 16 of the Exchange Act (including Rule 16b-3) that are requirements for the application of such exemptive rule, and the Plan and the Award Agreement shall be deemed amended to the extent necessary to conform to such
                  limitations.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fce0e71f8f2475ab55409b64d218d76">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.11</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Requirements of Law; Limitations on Awards.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc89beb04b6b4b06a13798ae95a7e768">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The granting of Awards and the issuance of Shares under the Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zedae05f7a8154e5d898aba2e269afc04">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>If at any time the Committee shall determine, in its discretion, that the listing, registration and/or qualification of Shares upon any securities exchange or under any state, Federal or non-United States law, or the consent or approval
                of any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the sale or purchase of Shares hereunder, the Company shall have no obligation to allow the grant, exercise or payment of any Award, or
                to issue or deliver evidence of title for Shares issued under the Plan, in whole or in part, unless and until such listing, registration, qualification, consent and/or approval shall have been effected or obtained, or otherwise provided
                for, free of any conditions not acceptable to the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda6e325654284b67afe00835240f50aa">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>If at any time counsel to the Company shall be of the opinion that any sale or delivery of Shares pursuant to an Award is or may be in the circumstances unlawful or result in the imposition of excise taxes on the Company or any
                Subsidiary or Affiliate under the statutes, rules or regulations of any applicable jurisdiction, the Company shall have no obligation to make such sale or delivery, or to make any application or to effect or to maintain any qualification or
                registration under the Securities Act, or otherwise with respect to Shares or Awards and the right to exercise or payment of any Option or Award shall be suspended until, in the opinion of such counsel, such sale or delivery shall be lawful
                or will not result in the imposition of excise taxes on the Company or any Subsidiary or Affiliate.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0fe8484eddc948e3ace672b04a7a9736">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Upon termination of any period of suspension under this Section 19.10(d), any Award affected by such suspension which shall not then have expired or terminated shall be reinstated as to all Shares available before such suspension and as
                to the Shares which would otherwise have become available during the period of such suspension, but no suspension shall extend the term of any Award.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd24a733539ea4712819eb3a61fa4e324">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Committee may require each person receiving Shares in connection with any Award under the Plan to represent and agree with the Company in writing that such person is acquiring such Shares for investment without a view to the
                distribution thereof, and/or provide such other representations and agreements as the Committee may prescribe.&#160; The Committee, in its absolute discretion, may impose such restrictions on the ownership and transferability of the Shares
                purchasable or otherwise receivable by any person under any Award as it deems appropriate.&#160; Any such restrictions shall be set forth in the applicable Award Agreement, and the certificates evidencing such shares may include any legend that
                the Committee deems appropriate to reflect any such restrictions.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 32 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze26af9c56fca4d49ae1c069cc45837e1">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>An Award and any Shares received upon the exercise or payment of an Award shall be subject to such other transfer and/or ownership restrictions and/or legending requirements as the Committee may establish in its discretion and may be
                referred to on the certificates evidencing such Shares, including restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under
                any blue sky or state securities laws applicable to such Shares.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1d9b0dc5923940e38df03cd48301053b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.12</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Participants Deemed to Accept Plan.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; By accepting any benefit under the Plan, each Participant and each person claiming under or through any such Participant shall be conclusively deemed to have indicated their acceptance and ratification of, and
                  consent to, all of the terms and conditions of the Plan and any action taken under the Plan by the Board, the Committee or the Company, in any case in accordance with the terms and conditions of the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7397f25071724c46b2e6ff597b41b226">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.13</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Governing Law.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The Plan and each Award Agreement shall be governed by the laws of the State of Delaware applicable to contracts made in and to be performed solely within the State of Delaware.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f7ec5bc31d54cbbb02957a54c5a1778">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.14</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Enforcement.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf69addb06dc64000af98d3b1bdc6890d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Any dispute arising under, related to or otherwise involving this Agreement or the Transactions will be litigated in the Court of Chancery of the State of Delaware.&#160; The Company agrees and by accepting an Award each Participant agrees to
                submit to the jurisdiction of the Court of Chancery of the State of Delaware and waive trial by jury.&#160; The Company and the Participants do not consent to mediate any disputes before the Court of Chancery.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4dc5a7b2a2444afb28de277660c6420">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Notwithstanding the foregoing, if there is a determination that the Court of Chancery of the State of Delaware does not have subject matter jurisdiction over any dispute arising under this Agreement, the Company agrees and each
                Participant by accepting an Award agrees that: (i) such dispute will be adjudicated only by, and will be subject to the exclusive jurisdiction and venue of, the Superior Court of Delaware of and for the County of New Castle; (ii) if the
                Superior Court of Delaware does not have subject matter jurisdiction over such dispute, then such dispute will be adjudicated only by, and will be subject to the exclusive jurisdiction and venue of, the Complex Commercial Litigation
                Division of the Superior Court of the State of Delaware of and for the County of Newcastle; and (iii) if the Complex Commercial Litigation Division of the Superior Court of the State of Delaware does not have subject matter jurisdiction
                over such dispute, then such dispute will be adjudicated only by, and will be subject to the exclusive jurisdiction and venue of, the United States District Court for the State of Delaware.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc69e6f8a71434acd9689b08a72b0ff80">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The Company and each Participant (by accepting an Award) irrevocably: (i) consents to submit itself to the personal jurisdiction of the Delaware courts in connection with any dispute arising under this Agreement; (ii) agrees that it will
                not attempt to deny or defeat such personal jurisdiction by motion or other request for relief from the Delaware courts or any other court or governmental body; and (iii) agrees that it will not bring any action arising under this Agreement
                in any court other than the Delaware courts.&#160; THE COMPANY AND EACH PARTICIPANT (BY ACCEPTING AN AWARD) IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON
                CONTRACT, TORT OR OTHERWISE) ARISING OUT OF THIS AGREEMENT, THE NEGOTIATION OR ENFORCEMENT HEREOF, THE ADMINISTRATION HEREOF, ANY AWARD AGREEMENT OR ANY AWARD.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 33 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18b4f5be31804f8b85f83dee62171e25">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>The court shall award attorneys&#8217; fees and expenses and costs to the substantially prevailing party in any action (including appeals) for the enforcement or interpretation of this Agreement.&#160; If there are cross claims in such action
                (including appeals), the court will determine which party is the substantially prevailing party as to the action as a whole and award fees, expenses and costs to such party.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4a9c976a93304e73b51f5c633233d219">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.15</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Plan Unfunded.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  The Plan shall be unfunded.&#160; The Company shall not be required to establish any special or separate fund or to make any other segregation of assets to assure the issuance of Shares or the payment of cash upon exercise or payment of any
                  Award.&#160; Proceeds from the sale of Shares pursuant to Options or other Awards granted under the Plan shall constitute general funds of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a8a59d7000442eebb537eb2b043cb3e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.16</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Uncertificated Shares.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; To the extent that the Plan provides for issuance of certificates to reflect the transfer of Shares, the transfer of such Shares may nevertheless be effected on a non-certificated basis, to the extent not prohibited by applicable
                  law or the rules of any stock exchange.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0030935e25e64b38833b16fd049a5efc">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.17</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">No Fractional Shares.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; An Option or other Award shall not be exercisable with respect to a fractional Share or the lesser of fifty shares or the full number of Shares then subject to the Option or other Award.&#160; No fractional Shares shall be issued upon
                  the exercise or payment of an Option or other Award.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf21e4eb503648ceb26b8a7c6ada9497">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18.18</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Participants Based Outside of the United States.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws or practices of countries other than the United States in which the Company, any Affiliate, and/or any
                  Subsidiary operates or has Employees, Non-Employee Directors or Consultants, the Committee, in its sole discretion, shall have the power and authority to:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z35ba6e40a3764746906686276f93de5b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Determine which Affiliates and Subsidiaries shall be covered by the Plan;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z97e1387af55a45ce8eb6066cd5d13c43">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Determine which Employees, Non-Employee Directors and/or Consultants outside the United States are eligible to participate in the Plan;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9fd382d6e1fb463dae031be30831b970">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Grant Awards (including substitutes for Awards), and modify the terms and conditions of any Awards, on such terms and conditions as the Committee determines necessary or appropriate to permit participation in the Plan by individuals
                otherwise eligible to so participate who are non-United States nationals or employed outside the United States, or otherwise to comply with applicable non-United States laws or conform to applicable requirements or practices of
                jurisdictions outside the United States;</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 34 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd0c3c2ed3cde429a8d9fd1df924b55b0">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Establish subplans and adopt or modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable.&#160; Any subplans and modifications to Plan terms and procedures established under this
                Section 19.16(d) by the Committee shall be attached to the Plan as appendices; and</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7cd54299fd634e2c80414496a98bd501">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Take any action, before or after an Award is made, that the Committee, in its discretion, deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate any applicable law.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ad5b3dab09e4e0eb171db1e8b9c281c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">DEFINITIONS.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;
                  Whenever used in the Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z180680bec2d04b2ba62d01fa5118f82e">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.1</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Affiliate&#8221; means any entity (other than the Company and any Subsidiary) (a) in which the Company owns or controls, directly or indirectly fifty percent or more of the voting power or economic interests of such entity, (b) that is
                affiliated with the Company through stock or equity ownership or otherwise and is designated as an Affiliate for purposes of the Plan by the Committee, (c) a partnership of which the Company or a Subsidiary of the Company is the general
                partnership or (d) a limited liability company of which the Company or a Subsidiary of the Company is the manager or managing member.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e1f5bd3dd154833a26804a9c8dc15c7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.2</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Assumed&#8221; means that pursuant to a transaction resulting in a Change of Control, either (a) the Award is expressly affirmed by the Company or (b) the contractual obligations represented by the Award are expressly assumed (and not simply
                by operation of law) by the surviving or successor corporation or entity to the Company, or any parent or subsidiary of either thereof, or any other corporation or entity that is a party to the transaction resulting in the Change of
                Control, in connection with such Change of Control, with appropriate adjustments to the number and kind of securities of such surviving or successor corporation or entity, or such other applicable parent, subsidiary, corporation or entity,
                subject to the Award and the exercise or purchase price thereof, which preserves the compensation element of the Award existing at the time of such Change of Control transaction, and provides for subsequent payout in accordance with the
                same (or more favorable) payment and vesting schedule applicable to such Award, as determined in accordance with the instruments evidencing the agreement to assume the Award.&#160; The determination of Award comparability for this purpose shall
                be made by the Committee, and its determination shall be final, binding and conclusive.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z12cd9bc42952457d880056ebca9668d7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.3</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Award&#8221; means, individually or collectively, a grant under the Plan of Non-Qualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units, Performance Shares, Performance
                Units, Cash-Based Awards, and Other Stock-Based Awards.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 35 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6dad8fca38f64c36890248383eca815c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.4</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Award Agreement&#8221; means either: (a) a written agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under the Plan, or (b) a written or electronic statement issued
                by the Company to a Participant describing the terms and provisions of such Award, including any amendment or modification thereof.&#160; The Committee may provide for the use of electronic, internet or other non-paper Award Agreements, and the
                use of electronic, internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z35bc1c029e794255b1cbd5dfb8307465">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.5</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Beneficial Ownership&#8221; (including correlative terms) shall have the meaning given such term in Rule 13d-3 promulgated under the Exchange Act.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb4e42c9c3d054880abe2fab62b0cd6f4">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.6</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Board&#8221; or &#8220;Board of Directors&#8221; means the Board of Directors of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19a6999a45d74101b8572c1f64428eeb">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.7</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Cash-Based Award&#8221; means an Award, whose value is determined by the Committee, granted to a Participant, as described in Article 8.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd3139668d1a549eca17ff54e0c0105c9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.8</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Cause&#8221; shall have the definition given such term in a Participant&#8217;s Award Agreement, or in the absence of any such definition, as determined in good faith by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf60832322ef64f78999785085f584580">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.9</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Change of Control&#8221; means the occurrence of any of the following:</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e6e2c85e0b8493eb37309d2d917b302">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>an acquisition in one transaction or a series of related transactions (other than directly from the Company or pursuant to Awards granted under the Plan or compensatory options or other similar awards granted by the Company) by any
                Person of any Voting Securities of the Company, immediately after which such Person has Beneficial Ownership of more than fifty percent of the combined voting power of the Company&#8217;s then outstanding Voting Securities; <font style="font-style: italic;">provided</font>, however, that in determining whether a Change of Control has occurred pursuant to this Section 2.9(a), Voting Securities of the Company which are acquired in a Non-Control Acquisition shall not
                constitute an acquisition that would cause a Change of Control; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc97cad35faf4a1081b2d003da880662">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>any Person acquires (or has acquired during the twelve-month period ending on the date of the most recent acquisition by such Person), other than directly from the Company or pursuant to Awards granted under the Plan or compensatory
                options or other similar awards granted by the Company, Beneficial Ownership of Voting Securities of the Company possessing thirty-five percent or more of the combined voting power of the Company&#8217;s then outstanding Voting Securities;
                provided, however, that in determining whether a Change of Control has occurred pursuant to this Section 2.9(b), Voting Securities of the Company which are acquired in a Non-Control Acquisition shall not constitute an acquisition that would
                cause a Change of Control; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2ed67f1db6a64c9ab12118980991d907">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>the individuals who, immediately prior to the Effective Date, are members of the Board (the &#8220;Company Incumbent Board&#8221;) cease for any reason to constitute at least a majority of the members of the Board; provided, however, that if the
                election, or nomination for election of any new director was approved by a vote of at least a majority of the Company Incumbent Board, such new director shall, for purposes of the Plan, be considered as a member of the Company Incumbent
                Board; provided further, however, that no individual shall be considered a member of the Company Incumbent Board if such individual initially assumed office as a result of either an actual or threatened &#8220;Election Contest&#8221; (as described in
                Rule 14a-12(c) promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (a &#8220;Company Proxy Contest&#8221;) including by reason of any agreement intended
                to avoid or settle any Election Contest or Company Proxy Contest; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 36 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z267c2159029c42d2b46637b32564b6de">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>the consummation of any merger, consolidation, recapitalization or reorganization involving the Company unless:</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4fe108ce4bb24e4e8c9e853ea61adb6f">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>the stockholders of the Company, immediately before such merger, consolidation, recapitalization or reorganization, own, directly or indirectly, immediately following such merger, consolidation, recapitalization or reorganization, more
                than fifty percent (50%) of the combined voting power of the outstanding Voting Securities of the corporation resulting from such merger or consolidation or reorganization (the &#8220;Company Surviving Corporation&#8221;) in substantially the same
                proportion as their ownership of the Voting Securities of the Company immediately before such merger, consolidation, recapitalization or reorganization; and</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb7c8324e84c47298b35b030ed8c7c1f">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>the individuals who were members of the Company Incumbent Board immediately prior to the execution of the agreement providing for such merger, consolidation, recapitalization or reorganization constitute at least a majority of the
                members of the board of directors of the Company Surviving Corporation, or a corporation Beneficially Owning, directly or indirectly, a majority of the voting securities of the Company Surviving Corporation, and</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4538cf4f23c64ec882a5d877e1cbdc63">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>no Person, other than (A) the Company, (B) any Related Entity, (C) any employee benefit plan (or any trust forming a part thereof) that, immediately prior to such merger, consolidation, recapitalization or reorganization, was maintained
                by the Company, the Company Surviving Corporation, or any Related Entity or (D) any Person who, together with its Affiliates, immediately prior to such merger, consolidation, recapitalization or reorganization had Beneficial Ownership of
                more than fifty percent of the then outstanding Voting Securities of the Company, owns, together with its Affiliates, Beneficial Ownership of more than fifty percent of the combined voting power of the Company Surviving Corporation&#8217;s then
                outstanding Voting Securities (a transaction described in clauses (d)(i) through (d)(iii) is referred to herein as a &#8220;Non-Control Transaction&#8221;); or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55a072b8f6164987a096f3e7f7296f4c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>any approval by the Company&#8217;s stockholders of any plan or proposal for the liquidation or dissolution of the Company; or</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z08948f4e9556406fb82c9a5353e35f75">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>any sale, lease, exchange, transfer or other disposition (in one transaction or a series of related transactions) of all or substantially all of the assets or business of the Company to any Person (other than (A) a transfer or
                distribution to a Related Entity, or (B) a transfer or distribution to the Company&#8217;s stockholders of the stock of a Related Entity or any other assets).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 37 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zbc18828f05f540f097dd4231d1a9227d" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div>Notwithstanding the foregoing, a Change of Control shall not be deemed to occur solely because any Person (the &#8220;Subject Person&#8221;) acquired Beneficial Ownership of more than fifty percent of the combined voting power of the then
                    outstanding Voting Securities of the Company as a result of the acquisition of Voting Securities of the Company by the Company which, by reducing the number of Voting Securities of the Company then outstanding, increases the
                    proportional number of shares Beneficially Owned by the Subject Persons, provided that if a Change of Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Securities by the Company and
                    (1) before such share acquisition by the Company the Subject Person becomes the Beneficial Owner of any new or additional Voting Securities of the Company in a related transaction or (2) after such share acquisition by the Company the
                    Subject Person becomes the Beneficial Owner of any new or additional Voting Securities of the Company which in either case increases the percentage of the then outstanding Voting Securities of the Company Beneficially Owned by the
                    Subject Person, then a Change of Control shall be deemed to occur.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd054e1db5ea64bf28b0b6ba8035880a3" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Solely for purposes of this Section 19.9, (1) &#8221;Affiliate&#8221; shall mean, with respect to any Person, any other Person that, directly or indirectly, controls, is
                  controlled by, or is under common control with, such Person, and (2) &#8221;control&#8221; (including with correlative meanings, the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any Person, means the
                  possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership of voting securities or by contract or otherwise.&#160; Any Relative (for this
                  purpose, &#8220;Relative&#8221; means a spouse, child, parent, parent of spouse, sibling or grandchild) of an individual shall be deemed to be an Affiliate of such individual for this purpose.&#160; None of the Company, any bona fide underwriter or
                  placement agent engaged by the Company or any Person controlled by the Company shall be deemed to be an Affiliate of any holder of Shares.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7552854399b64691a5fc589fe2bd2ff8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.10</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Code&#8221; means the Internal Revenue Code of 1986, as it may be amended from time to time, including rules and regulations promulgated thereunder and successor provisions and rules and regulations thereto.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4cb004f4ea604e2ab1da7797b73cdab8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.11</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Committee&#8221; means the Compensation Committee of the Board of Directors or a subcommittee thereof, or such other committee designated by the Board to administer the Plan each of whom satisfies such criteria of independence as the Board
                may establish and such additional regulatory or listing requirements as the Board may determine to be applicable or appropriate; provided, however, that with respect to Awards hereunder intended to qualify as performance-based compensation
                under Code Section 162(m), the Committee shall consist solely of two or more members of the Board who are not Employees and who otherwise qualify as &#8220;outside directors&#8221; within the meaning of Code Section 162(m).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed32bc0161794fc395b8234e1ebecca8">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.12</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Company&#8221; means Great Elm Group, Inc., a Delaware corporation.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 38 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf40eabd76a8041deadbbf822fbabcde6">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.13</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Consultant&#8221; means an independent contractor who is a natural person and performs services for the Company or a Subsidiary or Affiliate in a capacity other than as an Employee or Director.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z513b98aac83e4d379d21fedb949c931c">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.14</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Deferred Stock Unit&#8221; means a right to receive a specified number of shares of Shares during specified time periods.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z653da8b4164a4320aef1389a5da2ae94">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.15</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Director&#8221; means any individual who is a member of the Board of Directors of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f7ecc01e45243aeb9196e044bef9697">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.16</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Dividend Equivalents&#8221; means the equivalent value (in cash or Shares) of dividends that would otherwise be paid on the Shares subject to an Award but that have not been issued or delivered, as described in Article 10.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbccd38f0397a48ba80a12c747e0f7bf2">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.17</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Effective Date&#8221; means June 15, 2016, the date the Plan was originally approved (prior to its amendment and restatement) by the Company&#8217;s stockholders as contemplated in Section 1.1.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdba5b2e9a5854fcf9b84a063d88ee368">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.18</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Employee&#8221; means any person designated as an employee of the Company, a Subsidiary and/or an Affiliate on the payroll records thereof.&#160; An Employee shall not include any individual during any period he or she is classified or treated by
                the Company, a Subsidiary or an Affiliate as an independent contractor, a consultant, or any employee of an employment, consulting, or temporary agency or any other entity other than the Company, a Subsidiary and/or an Affiliate without
                regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company, a Subsidiary and/or an Affiliate during such period.&#160; For purposes of the
                Plan, upon approval by the Committee, the term Employee may also include Employees whose employment with the Company, a Subsidiary or an Affiliate has been terminated subsequent to being granted an Award under the Plan.&#160; For the avoidance
                of doubt, a Director who would otherwise be an &#8220;Employee&#8221; within the meaning of this Section 19.17 shall be considered an Employee for purposes of the Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ad3e57a09fd4b6cb5cc153b4289f2d3">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.19</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as it may be amended from time to time, including the rules and regulations promulgated thereunder and successor provisions and rules and regulations thereto.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z48fe03ed55ed42b2a9f0123054b31cff">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.20</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Fair Market Value&#8221; means the fair market value of the Shares as determined by the Committee by the reasonable application of such reasonable valuation method as the Committee deems appropriate; <font style="font-style: italic;">provided</font>,
                however, that, with respect to ISOs, for purposes of Section 5.3, such fair market value shall be determined subject to Code Section 422(c)(7); <font style="font-style: italic;">provided further</font>, however, that if the Shares are
                readily tradable on an established securities market, Fair Market Value on any date shall be the last sale price reported for the Shares on such market on such date or, if no sale is reported on such date, on the last date preceding such
                date on which a sale was reported.&#160; In each case, the Committee shall determine Fair Market Value in a manner that satisfies the applicable requirements of Code Section 409A.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 39 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z07e702933c7441c89bb1c59893bc653d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.21</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Fiscal Year&#8221; means the calendar year, or such other consecutive twelve-month period as the Committee may select.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7d3478a519eb4953b5411c5e6c73ad32">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.22</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Full Value Award&#8221; means any Award other than an Option, Stock Appreciation Right or Cash-Based Award.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8956b80004494ca3bae9220b78bcd88a">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.23</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Freestanding SAR&#8221; means an SAR that is granted independently of any Options, as described in Article 6.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6f44f98855fa4585925d6a6451e24108">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.24</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Good Reason&#8221; shall have the definition given such term in a Participant&#8217;s Award Agreement, or in the absence of any such definition, as determined in good faith by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d00ed1b3cd24af18ed518c25bca8f62">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.25</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Grant Price&#8221; means the price established at the time of grant of an SAR pursuant to Article 6, used to determine whether there is any payment due upon exercise of the SAR.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21f8abcf2f1649b6a9d7314198594b03">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.26</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Incentive Stock Option&#8221; or &#8220;ISO&#8221; means a right to purchase Shares under the Plan in accordance with the terms and conditions set forth in Article VI and which is designated as an Incentive Stock Option and which is intended to meet the
                requirements of Code Section 422.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdc77c25b45034b2cb7a8c50677f9c6bd">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.27</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Insider&#8221; means an individual who is, on the relevant date, an officer, director or ten percent Beneficial Owner of any class of the Company&#8217;s equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined
                by the Committee in accordance with Section 16 of the Exchange Act.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6dfe9279599149ef98c2d7113152e2e5">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.28</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Non-Control Acquisition&#8221; means an acquisition (whether by merger, stock purchase, asset purchase or otherwise) by (a) an employee benefit plan (or a trust forming a part thereof) maintained by (i) the Company or (ii) any corporation or
                other Person of which fifty percent or more of its total value or total voting power of its Voting Securities or equity interests is owned, directly or indirectly, by the Company (a &#8220;Related Entity&#8221;); (b) the Company or any Related Entity;
                (c) any Person in connection with a Non-Control Transaction; (d) any bona fide underwriter or placement engaged engaged by the Company in connection with the placement of securities of the Company or a Related Entity or (e) any Person that
                owns, together with its Affiliates, Beneficial Ownership of fifty percent or more of the outstanding Voting Securities of the Company on the Effective Date.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1011fb0bfb1b4a50aafa7c671933c1df">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.29</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Non-Employee Director&#8221; means a Director who is not an Employee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8a13978a736452cb69031cdf9c16806">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.30</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Non-Qualified Stock Option&#8221; or &#8220;NQSO&#8221; means a right to purchase Shares under the Plan in accordance with Article 4 and which is not intended to meet the requirements of Section 422 of the Code or otherwise does not meet such
                requirements.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zffe11211cf264a89b4f3802089ce0bd9">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.31</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Notice&#8221; means notice provided by a Participant to the Company in a manner prescribed by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 40 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e8d17517d3f4fbcab5c687750a86ed4">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.32</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Option&#8221; or &#8220;Stock Option&#8221; means an Incentive Stock Option or a Non-Qualified Stock Option, as described in Article 5.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z853f99e6cc2e4911833b8d607b4c8ce5">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.33</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Option Price&#8221; means the price at which a Share may be purchased by a Participant pursuant to an Option.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za699e6828e8545b29a17b2eeb8c3d875">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.34</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Other Stock-Based Award&#8221; means an equity-based or equity-related Award described in Section 9.1, granted in accordance with the terms and conditions set forth in Article 9, including Deferred Awards.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z705e78102463436a84c5e018ceb5eb8d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.35</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Participant&#8221; means any eligible individual as set forth in Article <font style="font-weight: bold;">4</font> who holds one or more outstanding Awards.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcea15c4fbe934fdca6a9c93fc89ea233">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.36</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Performance Period&#8221; means the period of time during which the performance goals must be met in order to determine the degree of payout and/or vesting with respect to, or the amount or entitlement to, an Award.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e9dddb817254955b88cfaf4927b8ffd">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.37</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Performance Share&#8221; means an Award of a performance share, whose initial value is equal to the Fair Market Value of a Share on the date of grant, granted to a Participant, as described in Article 8.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3bad19991b0f4817a411e7ede0901d22">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.38</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Performance Unit&#8221; means an Award of a performance unit, whose initial value is established by the Committee at the time of grant, granted to a Participant, as described in Article 8.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfda6378f26964b0baceebb8c81032198">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.39</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Period of Restriction&#8221; means the period during which Shares of Restricted Stock or Restricted Stock Units are subject to a substantial risk of forfeiture, and, in the case of Restricted Stock, the transfer of Shares of Restricted Stock
                is limited in some way, as provided in Article 7.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zde53f368668440bcb2bab0d9ea20ad52">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.40</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Person&#8221; means &#8220;person&#8221; as such term is used for purposes of Section 12(d) or 14(d) of the Exchange Act, including any individual, corporation, limited liability company, partnership, trust, unincorporated organization, government or any
                agency or political subdivision thereof, or any other entity or any group of persons.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z30e395ad492f462aa4cfcb7c32ae3129">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.41</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Plan&#8221; means this Great Elm Group, Inc. Amended and Restated 2016 Equity Incentive Compensation Plan, as amended from time to time.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd3c73349faaf438e951856d396586da2">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.42</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Qualified Change of Control&#8221; means a Change of Control that qualifies as a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company, within the meaning of
                Code Section 409A(a)(2)(A)(v).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb7438b45fda74487a7ae56c4b5d406b4">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.43</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Replaced&#8221; means that pursuant to a transaction resulting in a Change of Control, the Award is replaced with a comparable stock award or a cash incentive program by the Company, the surviving or successor corporation or entity to the
                Company, or any parent or subsidiary of either thereof, or any other corporation or entity that is a party to the transaction resulting in the Change of Control, in connection with such Change of Control, which preserves the compensation
                element of the Award existing at the time of such Change of Control transaction, and provides for subsequent payout in accordance with the same (or more favorable) payment and vesting schedule applicable to such Award, as determined in
                accordance with the instruments evidencing the agreement to assume the Award.&#160; The determination of Award comparability for this purpose shall be made by the Committee, and its determination shall be final, binding and conclusive.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 41 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z243e93e292c745b189c7087d1e0391c7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.44</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Restricted Stock&#8221; means an Award granted to a Participant, subject to the Period of Restriction, pursuant to Article 7.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2ab8530a847c481e8b35d232c854bf65">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.45</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Restricted Stock Unit&#8221; means an Award, whose value is equal to a Share, granted to a Participant, subject to the Period of Restriction, pursuant to Article <font style="font-weight: bold;">7</font>.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3f87f87a6024691996a49616d2cd659">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.46</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Rule 16b-3&#8221; means Rule 16b-3 under the Exchange Act, or any successor rule, as the same may be amended from time to time.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1aed1c1ed3df46c9ae8c4f49b05f24aa">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.47</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Securities Act&#8221; means the Securities Act of 1933, as it may be amended from time to time, including the rules and regulations promulgated thereunder and successor provisions and rules and regulations thereto.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z880d2560a8904f0a9df102cc5220c986">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.48</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Separation from Service&#8221; means a Termination that qualifies as a separation from service within the meaning of Code Section 409A(a)(2)(A)(i).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z97e35d0c88d84100ad28afcb63189c1f">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.49</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Share&#8221; means a share of common stock, par value $0.001 per share, of the Company (including any new, additional or different stock or securities resulting from any change in corporate capitalization as listed in Section <font style="font-weight: bold;">3.2</font>).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z238f3113c4f34e199a1c87c69b150ea3">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.50</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Stock Appreciation Right&#8221; or &#8220;SAR&#8221; means an Award, granted alone (a &#8220;Freestanding SAR&#8221;) or in connection with a related Option (a &#8220;Tandem SAR&#8221;), designated as an SAR, pursuant to the terms of Article 6.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z41593a5825a2433dbf144068970d4eb2">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.51</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Subsidiary&#8221; means any present or future corporation which is or would be a &#8220;subsidiary corporation&#8221; of the Company as the term is defined in Code Section 424(f).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f2475083cb74393ab0cb7067e9f8c66">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.52</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Substitute Awards&#8221; means Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, options or other awards previously granted, or the right or obligation to grant future options or other
                awards, by a company acquired by the Company, a Subsidiary and/or an Affiliate or with which the Company, a Subsidiary and/or an Affiliate combines, or otherwise in connection with any merger, consolidation, acquisition of property or
                stock, or reorganization involving the Company, a Subsidiary or an Affiliate, including a transaction described in Code Section 424(a).</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb5b7980d77e44a46b5c29a3390fd2e70">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.53</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Tandem SAR&#8221; means a SAR that is granted in connection with a related Option pursuant to Article 6.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">- 42 -</font></div>
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z59b144255be641bf82ac0f98f44694d6">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.54</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Termination&#8221; means the time when a Participant ceases the performance of services for the Company, any Affiliate or Subsidiary, as applicable, for any reason, with or without Cause, including a Termination by resignation, discharge,
                death, disability or retirement, but excluding (a) a Termination where there is a simultaneous reemployment (or commencement of service) or continuing employment (or service) of a Participant by the Company, Affiliate or any Subsidiary, (b)
                at the discretion of the Committee, a Termination that results in a temporary severance, and (c) at the discretion of the Committee, a Termination of an Employee that is immediately followed by the Participant&#8217;s service as a Non-Employee
                Director.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05d9512bec2f45d5b3e285b8033ec758">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19.55</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>&#8220;Voting Securities&#8221; shall mean, with respect to any Person that is a corporation, all outstanding voting securities of such Person entitled to vote generally in the election of the board of directors of such Person.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">- 43 -</font></div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>geg-20211117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://greatelmcap.com/20211117" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:geg="http://greatelmcap.com/20211117" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="geg-20211117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="geg-20211117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://greatelmcap.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>geg-20211117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>geg-20211117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://greatelmcap.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="geg-20211117.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://greatelmcap.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>brhc10030953_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="geg-20211117.xsd" xlink:type="simple"/>
    <context id="c20211117to20211117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831096</identifier>
        </entity>
        <period>
            <startDate>2021-11-17</startDate>
            <endDate>2021-11-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20211117to20211117"
      id="Fact_99d4f61e8e4f40849a17b64ce6dfb396">false</dei:AmendmentFlag>
    <dei:EntityAddressStateOrProvince
      contextRef="c20211117to20211117"
      id="Fact_2438d2ab36804d28a2ff1952957c3f94">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityCentralIndexKey
      contextRef="c20211117to20211117"
      id="Fact_9d264ab1f4f24887aebec4fe299451ce">0001831096</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20211117to20211117"
      id="Fact_70e56e426b8f45eeba28d1dff6b083d1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20211117to20211117"
      id="Fact_ad125f87080c4e55a74efeef1ebf12ef">2021-11-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20211117to20211117"
      id="Fact_5e4b5ac1e4aa4fcbb0133501b24bd4c1">Great Elm Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20211117to20211117"
      id="Fact_c99eae56869e4e0284857ef0675d3c42">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20211117to20211117"
      id="Fact_90e165dd9f32444badf8ad00ba146131">001-39832</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20211117to20211117"
      id="Fact_90359928a0904e55b0579e08bca08705">85-3622015</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20211117to20211117"
      id="Fact_92d696bfb1c54ded8b9dcacf8eac4ae8">800 South Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20211117to20211117"
      id="Fact_1b641dbee1084970bf96bcab19612793">Suite 230</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20211117to20211117"
      id="Fact_c58009346e9d4c62afa45ecad77be6ee">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20211117to20211117"
      id="Fact_60175c7b3bc647f39db297459603e1c9">02453</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20211117to20211117"
      id="Fact_25ddd4b00e6246eaa9c5ba670b2f1085">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20211117to20211117"
      id="Fact_b0e9492ac63541f79fb441de04e3376e">375-3006</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20211117to20211117"
      id="Fact_1bc6893a6b2747408db4991a7938812f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20211117to20211117"
      id="Fact_9728b49e4ab2427dbfd5ca0579d6ac5b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20211117to20211117"
      id="Fact_5c2351e510514b25bcf3ebc86f29997c">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20211117to20211117"
      id="Fact_f8d474153a054c5b8a8e69987320b388">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20211117to20211117"
      id="Fact_c0bbe2d30da145858748cc0022c8942d">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20211117to20211117"
      id="Fact_645dc4a3f551468eb8b832117b112a4a">GEG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20211117to20211117"
      id="Fact_00c22ce5c17949ada9d7bb3ba36ec805">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20211117to20211117"
      id="Fact_30f8e6b63480460ea3e6be79ada37151">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140301468016024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 17,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Great Elm Group, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-3622015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">800 South Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">375-3006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GEG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M"0Z3U%6 ]TNE[+[@#L?E?QO#?P!02P,$%     @ J(IQ4Y^@&_"Q @  X@P
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ J(IQ4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "HBG%3_C%_ ^T    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "HBG%3F5R<(Q &  "<)P  $P
M    @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *B*<5-H
M'B>?300  .<0   8              " @0P(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "HBG%3GZ ;\+$"  #B#   #0
M    @ &/#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *B*<5.7BKL<P
M !,"   +              "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M *B*<5,<.&7J/P$  #P"   /              "  500  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "HBG%3)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "H
MBG%399!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10030953_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://greatelmcap.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10030953_8k.htm">brhc10030953_8k.htm</File>
    <File>brhc10030953_ex10-1.htm</File>
    <File>geg-20211117.xsd</File>
    <File>geg-20211117_lab.xml</File>
    <File>geg-20211117_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10030953_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10030953_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "geg-20211117_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "geg-20211117_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "geg-20211117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "geg",
   "nsuri": "http://greatelmcap.com/20211117",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10030953_8k.htm",
      "contextRef": "c20211117to20211117",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://greatelmcap.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10030953_8k.htm",
      "contextRef": "c20211117to20211117",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://greatelmcap.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-21-038347-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-21-038347-xbrl.zip
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MR=6W;^?]_OG5Y4N")5>!]>=Q_^OYY=GMU:6 3MLG;5#%FFK5!275B&LKU05
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MA&/4'Q.'>8XN\D-TGL3H9 @.(*$?WP34G>"YES6I%PFFA&26?R?8#@A,*@C
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M0_TQ,^U?+NI"H_L*XZ.28E[$^*B&HWKMMLGCK,+6LPAA/8&'T9"RFTQM.G1
MW"BBI2G_)@^2V)+:PV3$<J/;4O'>RDTST<O/\86NXSJ.\SX$U)O=8;5RH\RS
M;U;>F)!^8?'#2&3]"/G+L>F:P-_RV B,C=C]G,BCT:CBBK#9O6 "2J_X3=(+
MQOPP\$."_OI\<[%MAMG3=RF]RLVG93[:<B?IA:%I+X=,FC]CUN:*/Q"RA0KR
M2JS#V;L*"/:.6DA&K<,.@V'EUM/%>?WD-[H^OH*;\=3ZYV>7Q[=_W/3Z.WK9
M]77A7NCT_NJ_)SZ=7RM:XXYVH>SB:W<23)&#)S&_@Q+D$4WE$ QC$Q0#V%
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M@<"@L K-<.P>-A*=:2:GYRR1TTI C5L9VB) CTUH3RMNKWQ2UF^OL#.P^%A
MK[,H1R5VPXHXL<F[.COY:D H.+I&\0YRY6S9J)\IUTDNB#(VK=4WK9J^U+^Y
MEDNB:9T208SB2&S0*0_^I#QX-.7!C]%QH7[IQUX>D#0#/R7("<W"DJ59R<,R
M2P^ZD4)XK'W#K_YV=GE^-;OZ]<?_[_S]]>SZT^SZ;^>SS[^<33W$][2M_82G
ME.1>D)(T2GU*>$9)&)1Y$9 H\ ^:?R.<>HC#,DA=AB3Q$L=Z]D68= 9TATSR
M+X#YV%'5-L!7#&+6Q@B4P]76YA584&H&@U0N7J9L*-7-TO1>9"J]+8SW#6=F
M5(T-O.__C5!5 M.98<J]<89X>S%]8QH;R_/<=%O\@.Y@,O=B;R[.G9Z+[(Z-
M#4<9OA 8C6X JOTPVZ/!>D($!1#%UL*DG:PMZ? TZ!9-7S?7/@KV1Q.WOKCZ
MI%(2=IFPG9T'9$2//A)\B3EX#\(SWKH6W:QZ=8RJZ&<.G0KF70!;^FR2J:E4
M<03%'LN_KBKUKBK9,A[R!=*U,*AKW:U4I4L0DJ#:7!H7 I#98GHM\$O/-5O3
MH,CR4A4YB:]?X7:5 SOIQXODY)R)'NMVSCJH+0\P;E_#5YN&WJ(;-]AX*D#A
MNBNMV_7K^?CFORZKM0[<]Y=ZRZ%37%D-R@0@MU-+!2Y\ESTRA2GJ+5?NM5#X
M>:QA0P"]]2J[<(-YHZUYBS <>_NWW9F7@;+Q^1]"4^:#<*!*"JD@BQ@&D=O0
MRC_-U79:J-\Z>K^9FH%%&C%'3):6H*[IE]*W ZS.@XO]K-S@K7=V3CSK3E('
M^QF\,NP:W"5O]2;O6N6.^=X[8)EL.6NO*>EI!3.!00NIWP\Q0U>]%E_6Y="=
M8C*.=@_M9'>OO%B"TP;25.YS74GXF"JQJJ^[QXF7"G,5KT2)QO5M!=L(W$*U
M 2%"X7K'G:CUYXB#0Z$\&&POO('?!!R=WNM*TMIH=C$8?E,C%]Z@6R0$M=2P
MC&B7DU#+I518-W^KQZ>X&%?#2:9]QYL;F>Y$O==*+!]H%C@@:QF]<2W!Q[.K
M#V?_/OM%E9UB #Q.POB$"H'T\3^OSO%/G!DQ]G>RW(BW;A;$"\].O6P^._O[
M^?\V7_H9PB[F.ZGO=_)K$$ZW4'-&9-Q7X^T]>NW]C6ZN=1_$ZZX\UIG;A [@
MB"5DLW.Q?%_( @F85.F06O)_;I8#]L-137_;!WUB;AALEQL"O$ZR&=8W#/]C
MO89GFF>)9XO](+$$&LZ&24[X0;(9VLU/RWJQJ._A^]LUGUESD(N,=0@4<G/3
MR #H4U^!,7CL^.!?-N^L,_27/V_>_8"1>74K+&[FBZ'2! $/]^"LKW0V*J9H
ME3RO!_V65#9=VRN@ 7?-7CU^_)2!%@==A0(:VGFOR==^678A? RE?B N/=9S
M! RGSEQ LDFZ%@>JLU\=YQOWS8CP2"%&F7F.L+BV&;U2,M8K[LQ)W9'F-[X>
M3AYFA-L?B<NX>)\R<CH &RGA/84OK2<<??@RGL*7QQCGR?TP#7TOC)*,165<
MDJ (O!2ZTT.MY6%3H0A_=XKSO'IW9@(#:'^<=1$0%4C9:XA'(MS[<';=J-U\
M+%2X,,Q;Y9+8SO1,P2B4Y=U56,L0Q0J]B?_J6<=*);V>JV0:5)\T'/>T;!>/
MVE-\TKMZKBQ<B<"K%Q4S7ZR;&[+4#SE1*+$M"#;0M_C8P670F5H:(6HFC)?5
MLM+C-@0.,-%>*C9,,C$3V_2YQVYT=F^[^8QIX])8P0Q2E%6QZ0U:+Z.N@I!>
MMXR[C:K67^N_M,*>7DLJ>F"5X_)CIT</WP1*'J'6ZK*<RP_>;%9S5?UDDIH:
MU]+Q6LVMT(;]J1G7HOJ-6]NAVT3 9THERSYV3"8+W<=OP=> ]A,F"W-M$55/
M8:V3XOD6#U&Z2MHG>GG;UT(,/(;?'0%'5;BJK<3I(<TCNW\(])'F?MNYZ(8J
M3#J4QMF96U[,7)&&@?GV&[#%PGIV5$ RB#-RH/M8)F%$OW7?TK4 \)2Y!OVL
MT#P^T<?/93AKAUR=9*M-J>Y2^GHP:,O&'7M%9J1"C J9+4.5 \_=M(([#=]:
M#1> )I2/"M%[G(?6\[:6K2'^6$+*X1*(&L/+996$E>.>7RX :*_]"1LHK@)U
M_0*L+I@R"I58,9)QN*(?L;3+L:3U)*L%[\5VU5?O GF315NKVOV.]<H9U;7T
M"M;[U\S(6X-\L6J4G-ZM&'3#2X!MF=X7JK+2!.>^J%JM[G'S[GSH327E1&O'
MR;H+^M_OOKXK*A,@STT/E>/$6=16Z:F%T"FP)-4=ENK"3_@(1%#W@Y,&1"3#
M0BJ:@15F<PUOZHL-4XW6=A[7KK<,>DN^Y-Y*[5X1V(-.9]<""9G5D( V:S@*
M2BE]OE&S1KEHH#;M#>WHZ8@21-QZYT-WW:('7E*>MRP@0%=7-7TMQQ=:A2ZN
M51B(E%%9"6G[:1I[WV+V!)6' P$%2V^VS/9BE$$NX%C\Y^-QA>* B/O$W N\
MB),XBP+.N5>481"4T6%3X8>GX>0*O7KWL9[]8I*:<&;>&]OLC/:#3GO+=_.O
M$@YJ"HS&16M=G@+B<%("=&*:8*88 8_B J'0I;32A5X(GG86+_4KD_!IICII
MK71\;:7$![K X3.YQ-[ \3'F>V>Y@V6F;M39[O#% D*"H,LLBQ[&T.4>!KX9
M]@^Q7"/&BS6T0="]@:4M*I/XXB-<=>G3D%M.F.JP)1=4UXWI-*)%)=I!%+IA
M2Y?)Z07B="W+%1F_"BA"E^I>&7DJ;ZX+RUI=@2A).HW/(O_>D@4WGD*I2KDD
MI-Z&TPMAQ:4B,6O9:Y32^1Y$6E@J\FJ7JD[J83^DP9F7,!\:BQ4L"H.B2+(D
M8TGL9:5/"GK0G<6B8P7ZG?]R\?/%CQ>_7%S_YWSV^>SR^N+]Q>>SZXM/'V=G
M'S_,+CY^N/C'Q8=?SWZ9_7+Q]XMK_,O5#/[Z'V>7'ZZFO;\G*KXL+8LH!O.(
M1Q&!ZKQ ;'PO#<.(L_2@J_.B"0V()TD,7U9E/>S5!G)IS'-50"UF^+%>OM&_
MF@IM&4]X;U5&=P4@.$P9IE'NHNWSJ.)^RL$_4K95KU+DZ64A(V(8&PYG"IX[
MMB7 S3D#4*X52$ZS$_)Z4L%[5L&D].(D]9F?\R@+2>'Y9<[2*(]S&N51>MAB
M:$I60;(*L0O=F=Y_<?#5KDX?W>%WE-^.RKSFJN*T+X+P:TBZK675\^4=0I@<
M-%.*60R]QSO  L&@N2&XFP3*GAONL+)@B9_EA!110+V<AU$2!D%(_"C/R4$W
MKHI>)N3S!QCU%TO,OX$<^*6O<Z5&GXA]_Z] !"43(N@896(<9[E/:)AF"8E(
MD&2,\#)D25[Z?G;@<0YA<W]G1I:X?#,2J(BNU1EYL"4@_PX(VOT86G;>\8Y\
MK>XV=^.L]9#N0&(4AH/2H 6;<G?YT..\4G'QGZH6@ #_*0Y<YRWZ,S'L!9B0
M'3II#'5W%]  EQ@UR7NHPP*P@J:CUX'V;>5.7:1=7- %XD<8#N)B#M:S':T&
M/'VS4DEG*V =ZGF:U<75['((B!OOH<;1FQV7.NCJMU%9P76O#J'SA4]:9\F7
M>05=!413*Q8:L2H+9P4,8L5Z^"^US-UKZ2/ [&QU!_<()C-XSR(_]8K C\N"
M1E&4>C2+T[),(YX4$6$D/^@:]I-B$OE:Y'>8&[<;^K(J0++X(%M[22H%Q++(
MW-FV2-U0"""&")OV2:Y$61A5+84010*7KES$+AP;J!#G"KB4R;J^D5A*+:)<
MX@Y1@SV6G15YT' R1.^XGU?6BDS3J;[^>^QA2? DS_9,R1Q&ON_'7EJ$PI_/
MT]SC>4)8&N8L*I+TH)MNQ<>:JKNZ_O3^?\T^?<84W+23][.3BZ#P6)D6<>:'
M$4M8GN5IF9:!GWLT\O+BL'?RE'@3=Y10:$?9VTM$N[NDU[:XM_8YQEJS%^2N
M5!-*#19',HU5KS6E(CE[O.%O.^Y$X" [FY3@?D5'2DGBE4'FD[R,8I;DM$QY
M0!.>QH2P_*#AC/&4+',T:-HSB2XQ\1AENC^U>Y+B_Y:%+*I;][ F1";8M&O
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M!NF*K83ZD#/HH %3[9-38]LRJ:N+UZ9+L[NY3<>L=L?%H6&JC_0CYU23X+7
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M>8HN S"*]SM8WB4\#1%J:XBV6/%I63L#UNL:Y8K,R*B@N96%*/A-M5P:R]\
M 37R0VEU=Y!D9L<I>(]'7-]D6[1XJ&LJ!('K^M8M-%?PKCJ2J[E%<F5:?O9"
M[RCZR6SP[@>/MM(W/3.<0FBK8PG<8<:C&-O^+-GE0X?\MC706]\^TJ:QT^/I
ML,F>@VS,RI IV[$S&S4D?^M6Z[KSZ28*3MBMW>A4(_=51YM!4M"VR' 76-?N
M(1=4@0VEFJ/ 9+JI]::%5IDZ/SOS8)WS7&T%3EG6\.@4<W/TAP>^!Y:RL%(
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MQQC\FT0LSS,N?J>D8$5"@S@\<'DWD=@;>??'40U;S^O(@WKNXN^E&=[=.7Z
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MY-M0XGALL]6MD<%6#:M;UIFJSC'%%-IPR_J1QX%.>R3%,LG1_2"@,P]JC<J
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MUEPH+X9A=V)L=#U!,RH& ?GYC,DFU*H@!,I/"KZ^YUPM"U%D ')656M*.31
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MRB(2%1DK>)ZEF<=93LKTH!M2BNT\0521L8R3M>GNL%F;=KXO0:JBRHV$Z:B
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MCM&#LS.A6>ZD6KODJP6AG)VZ?!VE63H>+XCO.R[6V(.!E[2H_K6I6"]B;&
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MX;,4&%1FG5":.:@(3[!T2!6'9GQ4TZ!6K;^I$1WD&=&NT.J8?&L\I2XPW^?
MBE]'<&GR.AE@)\Y VV,!;;X,M!DNH,USM*\\*-(\CP/!4Q[Y(F=1EHF 92S-
M><;%O%DQYXU\<=GYT5%V@U5=0$I+"!A2V)D$@.:.B!F8F)>MMV?601R':< ]
M7@8BC*2GG M9^$F2\DQDO(S2/PWF%*V]WS=3AO.V,<^8FJH3DZR;Z/HZ1$H<
MF>FZW?GD?/VCF"G^PH=6@Z;+>*I-3+9!GY_K):[XW]3-+^_3#4"<A=8YARCR
MBP/ES\7)=9';*&'PXNP !MJ/@ \@]FZ82R'*JSY0[2 NR6I[#\!>*J*6#U5]
M: $'4!2H7Z?%K.HAX]4D6:9NE GEPRT?&TB6[ @-O)O4N5G__E3%WB2)IOJ/
ML!),S]1&BM>.^F3*9WBU'>[1.^A&7P/IGT_*K'M#XPS)<2* -1)QM+6&\*@W
M!#(Z&)E!-BN-^Y@D*P;Z!;G5GCLB9385X]6FVC\-.6L3H/W0#;G66\+JJ@!^
MJ!Y 1NK=!?<9N8'H$0:8MH?-+7.28K#M.#M6ET.Y7"-O0E5V[\R<.R;!-2/H
M*+WP_GH[HMO3+4+S>B[\2XB(Z>U9:.@+\7S9HCZ7<K%W,-)KTZ:0UKU]7%VT
ME5)K4PX"95JQR-W8B;\>6U 4 /9'\A182'I(+H)+4\78(#>;:J2Z2_4+S"QH
MA+)CF(3=[:=!1R@R5+7$CV!EE6PT<,C8U=7%XF?FUSB^EL'.P&^Q_!BJ$Q#$
M;Q61-#7$Q9O+"<V[SKA1/:TV;,2&WQ?10^[,:@?'5;K T<^%D@C5[RDNM)7+
M7O"*B!5Z:DW4YQXJRD^"B^WE^O0STIU^O1SD<.G!\]W%@@ZAO9%+GH>77NJM
M8JK[$ZX@5I^T+=ARW%5TV*I>J4%!_B!C/PT5L4Z/CJ8Q+ \]]L5G1I/H42!7
M^K) -#] MKD/*\2M!1<M_JQU,9"8<I_J_TZO\^Y-[D:O$@S\GOU"4%."6_Z9
MV([JZ2Q^;X?K8Q,Q*B@.!44/GPN=V^)SXO>#V_9O11:5Z)NJO=%BWRE/I'\=
M?3'5^8W:$IOGB[?-"H?UK%H@U;*JMU5AF##-RC2EVQB[V6D&1NRH:0GU@J;:
M-[CDO\4!['IW?-#NV .]X&<'C/%:LRYB@IZJQZ@(::KSP[HDW(1LX; YY> D
M-DK QMZC':)731-N_W2/]]!F4>_9'?Z":M$1A/%[T K&%7JFEGG2*1Z<P=QC
MQ>@<ME"VF#J%@D5Q4O*,LS3*>)2+1/UOYK-<1CF/9EVKZD=+G0("T"Q*VJ[.
M=O6S809[WZLP?:,YO'_>'=H#B6>^JW<-!#XPK'T-B/,35S5\.NX_$ IJB]N.
M@_76B.W)<EZL7-*[4:%.47!>T^</W$+79@0J9$ZH;W>5.50>NDX#OVW7:\39
MMXZS<:QP05]XK*CB<E!-84T:];M4!]Q=44&D::^<0NL&#RY5GQBD.QQA1OI.
MG3.S'OC)]ZHWREG<2-)ZWZ'*\LO<-^NL39X8G'>#_&<N<,Q4HXA*%SI#0>IN
M V1:6^<<YPJ8WM> &82!L)^Z7JTYF7>U)^>JYGG2T)P0J4QSGN;*7D=!(;.<
M)W&1L4 9\)P5Y1*:6T)STWVZ,LYJMY"/BZ\/5J+Z_.;C^SY>%0MZ!@!@K+AO
M]_;6^#R\U[Y7*^2:HBE;\WPMT6MG3^D5@HWKP"@RA';7J/VXAHSHZB&>X;(C
M*/O?DH"]6/&*W'1PQ=WBKY$Q.D,'=<GFOBR;&RW9W',\UGB!* *>>H7T\BC(
MO-Q/DT 6J3K<9'&2QK,^UL3G6CSVZ>K_K/YY\^EO?WO_P]N;=]]CT=C[3W^[
M_K"";WZ\^O3I^L/'F3MM9S/%@S)@N>?Q("E9Y&=Q5HHRCK(R*N-<Q*68^11?
M2L=@P;!?49]0D\2?_MAM3I5:O@7^Z0CAJ$\ZE1PXUZGAOJL;=2]T_AYURRA'
MUB4J3(+"86H4A^$9C7)W1->DJ9J_DT#(!(J->^3?VM3JG:*G!:=QD"Y0-_T(
MW[509 V%WNJV>(PG+[5'QWTDN65:A"$"$\XF]00,8FIZ)V:Q>MU9MF[Z_&"?
MHX]WBJ:00H"KR:B3#":&ZC!9$B$3=,OU81NIO,K*DET^N8J;5A"S2RH,RL<@
M<#)Y7F\:B!_0@9W:J/I=-]9G[Y23>GTT=%RFCY:/P:6H,7VS]W68)Z VWAT'
MS9@.V!\D0T,M)7TM#LB1[KZ>F,/49<W@8%.5JD-;_9J?FP[3PXG2$%U5VC3H
M &(K&SV%G*XA"2D.045K@0Y8[LC#)7!<^MQ4&N?.SB3"<3:;913ZLLR$'TB6
M1*4'VZ1R":- 1HE@OC=O,H%X"7/#.#@;)2RW3Q"DP.@MY;-.NWE.J@;?RAUL
M8( 3Z:I\5GX"A"WC9.HX(4XUTH.LOK.+@-DA^]%#4TS*9!LF$M<D0?!7Z.2X
M#>=PU?,+=KF2&PI,3X:VZT[,S9A;N_OK=*&E_H$=4@*388?K%')3J7G7DVUS
M^^B"98!,1MVKTQVZ. G,R7$UP,G1!(/:B0%"<+M]3 ."0 ;"O=%D;;3==;[$
ME7ETYZWSM@ZMF5>F_!)997";=G_3X%U@USWZU/_0&8V?7W\T.R?,#37L]W4+
MR[1#4:@-L:FG 7'HG!ART4:.M/C4G[BQ 5:7_8J?J_O66WEIV@!HJ;U=EWU?
MP\ZCQYWL] O=67)!E*FCSV%8G5G3WM? ^_.?=04('P)5&&)*DON#UVV\%'QE
MK7H?IGY#ZYM,NDW6*73="_905\+MB?6*#/[)^-"M_@8S^L;-KKJ/4=.RT4E^
MS2WDIF]4%YI;$*=E+0$;75X#G<Z;9!MULOKZ,NN8:[Z_9[P/2[,U/2OP=9#Q
M@%EK@Z55T\B'6M.A8U 8[%2#UG*-*"R'"Z*G1+ESQ!H<"M"Q0&-#YM?U)0<N
MN+:QP/?>\U%';+^+0W5:A\HOF6"E!V42090G.4\*Z8<\#C,&+A:?N4,5+@[5
MG_[Z41VJ(0<+Z9WWW<;T5:(0CE]DBD!&;M M)%X -'N_M_AH8JP9;B60J)'-
MSN#A7&W6CKN@KR]!F2JC,5&:M!;AA,E#VC_6D_1YZFH,>5@9/_BA*V8X,)8#
MO3*$$.\DWKJ[LY&>M:$!W>HI]PEN4ERZ40R]E[$A_1Z,+ST"B(!@U."_UOB_
M/OI2A'HC!NGVO(:S'C@\0.^/Q!]T'.&XU+1]W=BGP<ONH2LT_I[$'U< # <H
M"Q(>443%,!ZI.6'09CKUB(A7$^T9CQ-@QO$Y:^.^V!T&E.X)SPFE0.!Z[HKN
MI*&V;.T=\&/H\N$T:V1)Z%(-&;3XT?Y T  L>]6)N6;45(KS) C#*(N\*,S2
M.!1%4J32RXL@G[4LF=JKHF6O4GN5/FQG()2^NM;NZ&FWJIMA,0\$%@D0K)\W
M!>VF%A%6 DY0XCBR@EFTEU5&<'8!LVTQ#=5&W</^#QK\;TL[&M4M#=QK7<?4
M'<VGE)=6]OPVW1]V.4'H2RZ[/NFK@2KJ^PZK:P=HL%&[D@;$40M')6.B[:^L
M7.4-@ "@%/,#8,H.T*KF 4RB(=EU@.SF&;O/)#:.%H!98N6N_ <#PLJ9V+65
M_L2-#V-\IB(]L8,%MND>:99U\Y<3X[;=U T5$C""MF(":SB:0W%&<=\%/?(R
M]$B\H$?.T6'( [\LO)@K[\"+U%KE85;XD>!<LC1A_MQ3Z_'B,"!Y__<'AIEJ
MW&F_8P\U!:@AZ?X):-W!_SZM!W&U@:S![5U_#T0\)3'-"RP>[)7:MC6=.S1J
MW9014HDJ'N8Z=0^GKG(]65#9)S;W\JMUKRFBEE0Y^8AY!G/><U*=;I)Y:L_$
M9E"YVQ/&6$L[KA!QWIMQG?(LH#UF#QR4L$';RZGH]MJ ]?LQ]0U[_&R*&';U
M3I3+=65*W0C5XC6^'@@[XI/NI7(^D #B"#JUYQZB'D/]2/5@6M7*> 48,5BO
M=!!_K19:2Y%1<SI<CY0NI]_"F;@$9V/<15'Z<2'R.&-Y5"2")TG$ C^-\C#D
M43GWTV!RIMC =VH-_]V4**_>0CP$(BAOG#+DN5.MG,T4SP1G+/< W2"C.)*Y
MG_B%#-,@2-(@B6:-=I@YN>Z-:ZCIK,T[M4$UH869V;T">\S E9A^.[8Q(FL[
MWK!D%;(A':5-F-[E=RXXSB;8=H<-):8AB_F-K36?2J'WPJ/CS4^C%ZB#;(,M
MZ75R2(G1U8H?U_AQN4*8\@_O&:2[5_=('@_;-&0(X2\=[KAPDZ*7.$3MR\;(
MICDU1PV0O Q)[+M76[GJA..QF'@#4X7ZG7\#9>Z5#8] K+IAC<NET;DN>IPQ
M@%XHZR+[E(08\ :X67$G!5)EE"8)TL';,&I!Z6N7R:*C'>C1]8_':K'$)ZI#
M8%E<%%XH@S2,DC3G?AG$/$Q2F95!PF:=)ITYE_-0;ZNWWGJ4&.-5YZIKT<(S
M<3FP;$,FDNQU I:T6S+5L-1LJHZVNQU9=7T\T"FM:NMF+)FU27B*&F\18PNT
M+--3HAF8"'Q>^K*(9>2I=9FRP&-%7N9IY)5\89$^E>QIM\LYI+LZF0W<.R9S
MVJ>! ;*0U=4]I($KV@L_&"E$9_/N5AY^@-LN+3T2BG.H:#YS4RZ10\S!)AWW
M)G9#/V:\5!UE\<[9ZJ/15C4D5<C%47U_]_>/[\=<PM:G@U<)F6W4']0C269)
M QV,;R".*D/K@1ADCZQOYJ:PW>MI/!^J>H.XLBZ_[U!G DO!"61V-,]R]T(%
M=D>WR\R9[IW"<&%9<F_,AE/$7@Z"B/HRC61$)%XC@*F'$E*0G"$?=J3,;1TK
M.]+CUSX8^M\P)"_X17EH())V9 R?'SR:3W)'LICP1G7:42N5HRBY5I8<H&?<
M.8%</^/NTU11V^RFWMVJ6YA)@S^%.;+L7J>*:"5>64:IB-,RB]1R5/^3%9%R
M,;F0A?IXUKO7O*GA?Y[2.-6KU&$E0.LQV@G6=%+]H#&M&+V&30="V>O53QTE
MW\0G" 98K]ZP]N[5MPALUA "0BJ1#C'>KO>UW2+N687PJ1*._Z:TR8E=P[IT
M%_Q$L+NLU-)7W;@#0V!/G\HTB-6VAH\=T[ 3738<F+_4.Y+ V$B@M\J<WIT
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M8@"F5CTR>*MFCOG774L/N<<([<CMZ\(47>$./>-(K.N(G[<X)B<^$091%+#
MCY(XBQ(_SE@.DN(LXP%C193-W#')%L?D3W_]H6:G)ECY]%E&3"N2U<<D#$Y)
MZ,((0JTWJVT-O,G06K"GCA?0'E/)<A&(CDMB$>,F#:>CCD/OXAOK/(&6]R,
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MHR!3SE;*2NEY61@'D5?&'ILUN<U%<4[&W='='EL9;FG(ZOMJ9TNT\0)MN";
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M9O&T1C,-\[0,8B_UTR JHH0',BG+.$]YY/,@F'6 &8SFHIZA[O@](C3 ]OS
M'K\ZI_PGUSR@!3R*7![6UZ,G9$(MZ":I/]Y*]3$J:_5<)!+N!8)15&FL=@:7
MQC'P##AGB)+7&[";8#]T9&1TW\5DG-9D1&4JBY@7H2_BJ."<>T$>ITS].V9^
MFLX:^PDFXZNH4/P!,.=K(F?7?%7+7#X-!WNN&L2]1!1)I*YF99Z)D/M<_9WE
MGICS7)XYCADBVJ)J[R%6SYJJM:XQ0-LV3-?_](+IU>ZAWCQ00J-JG0U%.Y+(
MMLXLQ9%&.52H4]M5*KTQ0AEO[L"W[&CYQCM#/]- ##_P4"V(WC\;6-6^X4&
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MD]G';<]!WL<<\\<.H(XT.&DN"@S8*O<1#,4--:AU]1\(('%1(+3;W;,G )+
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MCIB0Z03G$$[JI].<PL[J/T:#O&RPIXJP,!'*&$@ 2A'QI.!Q4?AQR*,@R\M
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MI8MF&#B_XV4]RJ1.V*2.&V'J$<O"/]795)0R#](\SG,_RJ4ZIA:!2'T_].-
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MF"!H')!%]N12QX3%]!EDO!&S2R.XA)1.YEA[,LQC)M0!MHR2@+&H* N>%F'
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M<:D(IU"UC]0:4#4^]XM)9ZH73BUS*%,R(7)LC=V,C1,'(>Z%#B2%VH=:3^V
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M?:Q:-\T'?>UJ:6U#OG:YRJS$<0>K7.JF^:!O,0U)<!X'[0]<[<K5X.]3CW:
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M>G77G8KO<"RMQ14[XM_\6S2%^3?ESOX'4$L#!!0    ( *B*<5,-N?*>Y04
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MD5_DWVI__ ]02P$"% ,4    " "HBG%3-0MD29D6  #DW   $P
M    @ $     8G)H8S$P,#,P.34S7SAK+FAT;5!+ 0(4 Q0    ( *B*<5,I
MG(9Z$\L   / !0 7              "  <H6  !B<FAC,3 P,S Y-3-?97@Q
M,"TQ+FAT;5!+ 0(4 Q0    ( *B*<5,AX-*U5 ,  'D/   0
M  "  1+B  !G96<M,C R,3$Q,3<N>'-D4$L! A0#%     @ J(IQ4_.$* 6!
M"   <E@  !0              ( !E.4  &=E9RTR,#(Q,3$Q-U]L86(N>&UL
M4$L! A0#%     @ J(IQ4PVY\I[E!0  ]#X  !0              ( !1^X
K &=E9RTR,#(Q,3$Q-U]P<F4N>&UL4$L%!@     %  4 2 $  %[T      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
